575 results on '"Ojetti, V."'
Search Results
2. 78 Validation of ANCOC Score for Prognosis of COVID-19 in Different SARS-CoV-2 Variants
- Author
-
Fernández, M.S., primary, Candelli, M., additional, Pignataro, G., additional, Balsamo, I., additional, Rozzi, G., additional, Novelli, M., additional, Ojetti, V., additional, Gemma, S., additional, Piccioni, A., additional, and Franceschi, F., additional
- Published
- 2023
- Full Text
- View/download PDF
3. IS SOFA SCORE RELIABLE IN A GYNECOLOGIC ONCOLOGY SETTING OR IS SOMETHING MISSING? A RETROSPECTIVE STUDY ON PREDICTORS AND RISK FACTORS FOR BLOODSTREAM INFECTIONS: EP704
- Author
-
Corrado, G, Franza, L, Costantini, B, Spanu, T, Covino, M, Ojetti, V, Quagliozzi, L, Biscione, A, Taccari, F, Fagotti, A, Tamburrini, E, and Scambia, G
- Published
- 2019
- Full Text
- View/download PDF
4. Oral vs. IV paracetamol for pain control in patients with femur fracture in the emergency department: a practical randomized controlled trial
- Author
-
Franceschi, Francesco, Saviano, Angela, Covino, Marcello, Candelli, Marcello, Ojetti, Veronica, Cicchinelli, S., Petrucci, M., Sardeo, F., Torelli, E., Nicolo, R., Forte, Enrica, Maccauro, Giulio, Franceschi F. (ORCID:0000-0001-6266-445X), Saviano A. (ORCID:0000-0002-2820-7180), Covino M. (ORCID:0000-0002-6709-2531), Candelli M. (ORCID:0000-0001-8443-7880), Ojetti V. (ORCID:0000-0002-8953-0707), Forte E., Maccauro G. (ORCID:0000-0002-7359-268X), Franceschi, Francesco, Saviano, Angela, Covino, Marcello, Candelli, Marcello, Ojetti, Veronica, Cicchinelli, S., Petrucci, M., Sardeo, F., Torelli, E., Nicolo, R., Forte, Enrica, Maccauro, Giulio, Franceschi F. (ORCID:0000-0001-6266-445X), Saviano A. (ORCID:0000-0002-2820-7180), Covino M. (ORCID:0000-0002-6709-2531), Candelli M. (ORCID:0000-0001-8443-7880), Ojetti V. (ORCID:0000-0002-8953-0707), Forte E., and Maccauro G. (ORCID:0000-0002-7359-268X)
- Abstract
Femur fracture (FF) is a common reason for admission to the Emergency Department (ED) and pain is a frequent symptom. Effective and timely pain control is essential for these patients, however, the most appropriate analgesic therapy for quick pain relief in the ED setting is not well established. This is a single-center pragmatic randomized controlled study. We have enrolled 171 consecutive patients with FF and severe pain. They were randomized 1:5 to receive treatment with paracetamol 1000 mg orally (OR) or with paracetamol 1000 mg intravenously (IV). The effect on pain relief was measured with the Visual Analogue Scale for Pain (VAS) at baseline (T0), after 1 hour (T1), 2 hours (T2), and 4 hours (T4). The primary endpoint was the reduction of pain of 1 point of the VAS at T1. This target was reached by 75% of patients treated with paracetamol IV and 44% treated with paracetamol OR (p = 0.001). The secondary endpoint was the reduction of pain of at least 2 points of the VAS at T4, the need for rescue therapy, and the number of adverse events. At T4 the efficacy of paracetamol IV and OR resulted in 89.5% and 88.9%, respectively (p = 0.914). The 17.5% of patients treated with paracetamol IV vs. the 3.7% treated with paracetamol OR required rescue therapy (p = 0.082), with prevalence among women (p = 0.057). No adverse effects were reported. The treatment with paracetamol 1000 mg IV and OR resulted effective and safe for patients with FF waiting for surgery. IV administration was faster in reducing pain in the first 2 hours compared to oral administration but the latter required less rescue therapy. Interestingly, our study highlighted gender differences in pain relief opening the way for a gender-tailored therapy.
- Published
- 2023
5. Treatment of fever and associated symptoms in the emergency department: which drug to choose?
- Author
-
Franceschi, Francesco, Saviano, Angela, Carnicelli, A., Lorusso, C., Novelli, A., Candelli, Marcello, Ojetti, Veronica, Covino, Marcello, Franceschi F. (ORCID:0000-0001-6266-445X), Saviano A. (ORCID:0000-0002-2820-7180), Candelli M. (ORCID:0000-0001-8443-7880), Ojetti V. (ORCID:0000-0002-8953-0707), Covino M. (ORCID:0000-0002-6709-2531), Franceschi, Francesco, Saviano, Angela, Carnicelli, A., Lorusso, C., Novelli, A., Candelli, Marcello, Ojetti, Veronica, Covino, Marcello, Franceschi F. (ORCID:0000-0001-6266-445X), Saviano A. (ORCID:0000-0002-2820-7180), Candelli M. (ORCID:0000-0001-8443-7880), Ojetti V. (ORCID:0000-0002-8953-0707), and Covino M. (ORCID:0000-0002-6709-2531)
- Abstract
OBJECTIVE: Fever is a frequent cause of admission to the Emergency Department (ED) worldwide. Although it can be caused by a wide range of conditions, the most effective treatment based on its etiology is still undetermined. PATIENTS AND METHODS: This prospective, single-center, observational study enrolled adult patients who accessed the ED for fever. Physicians were free to administer paracetamol 1,000 mg (P), the combination paracetamol 500 mg/ibuprofen 150 mg (PI) or Ibuprofen 600 mg (I). The primary endpoint was both 1-degree and 1-point reduction in body temperature for all associated symptoms on the Numerical Rating Scale (NRS) after 1 hour (T1). The secondary endpoint was the reduction of at least 2 points on the NRS after two hours (T2). Adverse events, the need for rescue therapy, and the response based on the underlying etiology (bacterial, viral, or immune/neoplastic) were also evaluated. RESULTS: 324 patients (170 males, mean age 71±6 years) were enrolled: 187 had bacterial, 80 viral, and 57 neoplastic/inflammatory fever. Fever was treated with Paracetamol 1,000 mg (P) in 189 patients and with Paracetamol/Ibuprofen 500/150 mg (PI) in 135 subjects, while none of the patients were primarily treated with I. Based on the fever etiology P was administered to 113 patients with bacterial fever (59.8%), 48 patients with viral fever (25.4%), and 28 subjects with neoplastic/inflammatory fever (14.8%). PI was administered to 74 patients with bacterial fever (54.8%), 32 patients with viral fever (23.7%), and 29 subjects with neoplastic/inflammatory fever (21.5%). The primary endpoint was achieved by 126 patients, 70 of them (37.0%) were treated with P and 56 (41.5%) with PI (p=0.418). The secondary endpoint was achieved by 295 patients, 171 (90.5%) of them treated with P and 124 (91.9%) treated with PI (p=0.669). No significant differences were found between groups treated with P and PI concerning rescue therapy (15 vs. 6 patients; p=0.893). Interestingly, PI was m
- Published
- 2023
6. Current Trends for Delirium Screening within the Emergency Department
- Author
-
Saviano, Angela, Zanza, C., Longhitano, Y., Ojetti, Veronica, Franceschi, Francesco, Bellou, A., Voza, A., Ceresa, I. F., Savioli, G., Saviano A. (ORCID:0000-0002-2820-7180), Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), Saviano, Angela, Zanza, C., Longhitano, Y., Ojetti, Veronica, Franceschi, Francesco, Bellou, A., Voza, A., Ceresa, I. F., Savioli, G., Saviano A. (ORCID:0000-0002-2820-7180), Ojetti V. (ORCID:0000-0002-8953-0707), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Delirium is an acute neurological disorder that involves attention and cognition. It is associated with a high risk of morbidity and mortality among older people (>65 years old). In the context of the Emergency Department (ED), it is frequently experienced by patients but often not recognized. Literature studies have identified some screening instruments for an initial evaluation of delirium. Most of these tools have not been validated yet in the context of emergencies, but, in other settings, they were very useful for assessing and maximizing the recognition of this condition among older patients. We conducted a review of the literature, including randomized control trials, clinical and observational studies, and research studies published in recent years, confirming that most of the screening tools for delirium used in the intensive care unit (ICU) or the geriatric department have not been tested in the ED, and the ideal timing and form of the delirium assessment process for older adults have not been defined yet. The aim of our review is to summarize the updated evidence about the screening tools for delirium in the context of the ED, due to the fact that overcrowding of the ED and the stressful condition of emergency situations (that contribute to the onset of delirium) could expose older patients to a high risk of complications and mortality if delirium is not promptly recognized. In conclusion, we support the evidence that delirium is a current and real condition that emergency physicians have to face daily, and we are aware that more research is needed to explore this field in order to improve the overall outcomes of older patients admitted to the ED.
- Published
- 2023
7. Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease
- Author
-
Saviano, Angela, Petruzziello, C., Brigida, M., Morabito Loprete, Maria Rita, Savioli, G., Migneco, Alessio, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Morabito Loprete M. R., Migneco A., Ojetti V. (ORCID:0000-0002-8953-0707), Saviano, Angela, Petruzziello, C., Brigida, M., Morabito Loprete, Maria Rita, Savioli, G., Migneco, Alessio, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Morabito Loprete M. R., Migneco A., and Ojetti V. (ORCID:0000-0002-8953-0707)
- Abstract
Celiac disease (CD) is a chronic inflammation of the small intestine triggered by gluten ingestion in genetically predisposed people. Recent literature studies highlight the possible role of the gut microbiota in the pathogenesis of this disease. The gut microbiota is a complex community of microorganisms that can interact with the innate and adaptative immune systems. A condition of dysbiosis, which refers to an alteration in the composition and function of the human gut microbiota, can lead to a dysregulated immune response. This condition may contribute to triggering gluten intolerance, favoring the development and/or progression of CD in genetically susceptible patients. Interestingly, studies on children and adults with CD showed a different microbiome profile in fecal samples, with a different degree of “activity” for the disease. From this point of view, our review aimed to collect and discuss modern evidence about the alteration of the gut microbiota and its modulation with probiotics, with possible future indications in the management of patients affected by CD.
- Published
- 2023
8. Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection
- Author
-
Saviano, Angela, Brigida, M., Petruzziello, C., Zanza, C., Candelli, Marcello, Morabito Loprete, Maria Rita, Saleem, Faiz Ur Rehman, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Candelli M. (ORCID:0000-0001-8443-7880), Morabito Loprete M. R., Saleem F., Ojetti V. (ORCID:0000-0002-8953-0707), Saviano, Angela, Brigida, M., Petruzziello, C., Zanza, C., Candelli, Marcello, Morabito Loprete, Maria Rita, Saleem, Faiz Ur Rehman, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Candelli M. (ORCID:0000-0001-8443-7880), Morabito Loprete M. R., Saleem F., and Ojetti V. (ORCID:0000-0002-8953-0707)
- Abstract
Background: The virus SARS-CoV-2 is responsible for respiratory disorders due to the fact that it mainly infects the respiratory tract using the Angiotensin-converting enzyme 2 (ACE2) receptors. ACE2 receptors are also highly expressed on intestinal cells, representing an important site of entry for the virus in the gut. Literature studies underlined that the virus infects and replicates in the gut epithelial cells, causing gastrointestinal symptoms such as diarrhea, abdominal pain, nausea/vomiting and anorexia. Moreover, the SARS-CoV-2 virus settles into the bloodstream, hyperactivating the platelets and cytokine storms and causing gut–blood barrier damage with an alteration of the gut microbiota, intestinal cell injury, intestinal vessel thrombosis leading to malabsorption, malnutrition, an increasing disease severity and mortality with short and long-period sequelae. Conclusion: This review summarizes the data on how SARS-CoV-2 effects on the gastrointestinal systems, including the mechanisms of inflammation, relationship with the gut microbiota, endoscopic patterns, and the role of fecal calprotectin, confirming the importance of the digestive system in clinical practice for the diagnosis and follow-up of SARS-CoV-2 infection.
- Published
- 2023
9. Effects of functional foods, nutraceuticals, and herbal products on pancreas
- Author
-
Saviano, Angela, Zanza, C., Longhitano, Y., Nista, Enrico Celestino, Franceschi, Francesco, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Nista E. C., Franceschi F. (ORCID:0000-0001-6266-445X), Ojetti V. (ORCID:0000-0002-8953-0707), Saviano, Angela, Zanza, C., Longhitano, Y., Nista, Enrico Celestino, Franceschi, Francesco, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Nista E. C., Franceschi F. (ORCID:0000-0001-6266-445X), and Ojetti V. (ORCID:0000-0002-8953-0707)
- Abstract
N/A
- Published
- 2023
10. The Interplay between Helicobacter pylori and Gut Microbiota in Non-Gastrointestinal Disorders: A Special Focus on Atherosclerosis
- Author
-
Candelli, Marcello, Franza, Laura, Cianci, Rossella, Pignataro, G., Merra, Giuseppe, Piccioni, Andrea, Ojetti, Veronica, Gasbarrini, Antonio, Franceschi, Francesco, Candelli M. (ORCID:0000-0001-8443-7880), Franza L., Cianci R. (ORCID:0000-0001-5378-8442), Merra G., Piccioni A., Ojetti V. (ORCID:0000-0002-8953-0707), Gasbarrini A. (ORCID:0000-0002-7278-4823), Franceschi F. (ORCID:0000-0001-6266-445X), Candelli, Marcello, Franza, Laura, Cianci, Rossella, Pignataro, G., Merra, Giuseppe, Piccioni, Andrea, Ojetti, Veronica, Gasbarrini, Antonio, Franceschi, Francesco, Candelli M. (ORCID:0000-0001-8443-7880), Franza L., Cianci R. (ORCID:0000-0001-5378-8442), Merra G., Piccioni A., Ojetti V. (ORCID:0000-0002-8953-0707), Gasbarrini A. (ORCID:0000-0002-7278-4823), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
The discovery of Helicobacter pylori (H. pylori) in the early 1980s by Nobel Prize winners in medicine Robin Warren and Barry Marshall led to a revolution in physiopathology and consequently in the treatment of peptic ulcer disease. Subsequently, H. pylori has also been linked to non-gastrointestinal diseases, such as autoimmune thrombocytopenia, acne rosacea, and Raynaud’s syndrome. In addition, several studies have shown an association with cardiovascular disease and atherosclerosis. Our narrative review aims to investigate the connection between H. pylori infection, gut microbiota, and extra-gastric diseases, with a particular emphasis on atherosclerosis. We conducted an extensive search on PubMed, Google Scholar, and Scopus, using the keywords “H. pylori”, “dysbiosis”, “microbiota”, “atherosclerosis”, “cardiovascular disease” in the last ten years. Atherosclerosis is a complex condition in which the arteries thicken or harden due to plaque deposits in the inner lining of an artery and is associated with several cardiovascular diseases. Recent research has highlighted the role of the microbiota in the pathogenesis of this group of diseases. H. pylori is able to both directly influence the onset of atherosclerosis and negatively modulate the microbiota. H. pylori is an important factor in promoting atherosclerosis. Progress is being made in understanding the underlying mechanisms, which could open the way to interesting new therapeutic perspectives.
- Published
- 2023
11. Lower Gastrointestinal Bleeding in the Emergency Department: High-Volume vs. Low-Volume Peg Bowel Preparation for Colonoscopy: A Randomized Trial
- Author
-
Saviano, Angela, Petruzziello, C., Riccioni, Maria Elena, Di Pumpo, M., Petrucci, M., Brigida, M., Zanza, C., Candelli, Marcello, Franceschi, Francesco, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Riccioni M. E. (ORCID:0000-0002-9239-4312), Candelli M. (ORCID:0000-0001-8443-7880), Franceschi F. (ORCID:0000-0001-6266-445X), Ojetti V. (ORCID:0000-0002-8953-0707), Saviano, Angela, Petruzziello, C., Riccioni, Maria Elena, Di Pumpo, M., Petrucci, M., Brigida, M., Zanza, C., Candelli, Marcello, Franceschi, Francesco, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Riccioni M. E. (ORCID:0000-0002-9239-4312), Candelli M. (ORCID:0000-0001-8443-7880), Franceschi F. (ORCID:0000-0001-6266-445X), and Ojetti V. (ORCID:0000-0002-8953-0707)
- Abstract
Background: Lower Gastrointestinal Bleeding (LGIB) is a common cause of admission to the Emergency Department (ED). Early colonoscopy is the exam of choice for evaluating LGIB, and an adequate colon cleansing is essential. High-volume solution 4L-PEG is largely used, but it has some limitations. Low-volume solution 2L-PEG may improve patient’s tolerability and compliance, reducing the time of administration and speeding up the exam. Patients and Methods: We conducted a randomized 1:1, prospective observational monocentric study in 228 patients (144M/84F) with LGIB. 121 (69M/52F) received the High-Volume, while 107 (75M/32F) received Low-Volume. They completed a “satisfaction questionnaire” (taste and smell, mood, time of taking, general experience). We collected the results of the Boston Bowel Preparation Scale (BBPS) and the final diagnosis. Results: A mean value of BBPS 6,3 was achieved by both groups (p=0.57). Regarding smell, taste, mood and time of taking (1 to 5), we do not find any statistically differences. The overall satisfaction between the two preparations was 2.90 for low-volume compared to 3.17 for High-volume (p=0.06). No side effects were reported. The proportion of patients without an evident source of bleeding was higher in High volume preparations compared to Low-volume (39% vs. 30%, respectively). Conclusion: Low volume bowel preparation showed the same efficacy and tolerability with better satisfaction compared with high volume. Low-volume could represent an effective and more desirable preparation for patients in the ED.
- Published
- 2023
12. Treatment of fever and associated symptoms in the emergency department: which drug to choose?
- Author
-
FRANCESCHI, F., SAVIANO, A., CARNICELLI, A., LORUSSO, C., NOVELLI, A., CANDELLI, M., OJETTI, V., and COVINO, M.
- Abstract
OBJECTIVE: Fever is a frequent cause of admission to the Emergency Department (ED) worldwide. Although it can be caused by a wide range of conditions, the most effective treatment based on its etiology is still undetermined. PATIENTS AND METHODS: This prospective, single-center, observational study enrolled adult patients who accessed the ED for fever. Physicians were free to administer paracetamol 1,000 mg (P), the combination paracetamol 500 mg/ibuprofen 150 mg (PI) or Ibuprofen 600 mg (I). The primary endpoint was both 1-degree and 1-point reduction in body temperature for all associated symptoms on the Numerical Rating Scale (NRS) after 1 hour (T1). The secondary endpoint was the reduction of at least 2 points on the NRS after two hours (T2). Adverse events, the need for rescue therapy, and the response based on the underlying etiology (bacterial, viral, or immune/neoplastic) were also evaluated. RESULTS: 324 patients (170 males, mean age 71±6 years) were enrolled: 187 had bacterial, 80 viral, and 57 neoplastic/inflammatory fever. Fever was treated with Paracetamol 1,000 mg (P) in 189 patients and with Paracetamol/Ibuprofen 500/150 mg (PI) in 135 subjects, while none of the patients were primarily treated with I. Based on the fever etiology P was administered to 113 patients with bacterial fever (59.8%), 48 patients with viral fever (25.4%), and 28 subjects with neoplastic/inflammatory fever (14.8%). PI was administered to 74 patients with bacterial fever (54.8%), 32 patients with viral fever (23.7%), and 29 subjects with neoplastic/inflammatory fever (21.5%). The primary endpoint was achieved by 126 patients, 70 of them (37.0%) were treated with P and 56 (41.5%) with PI (p=0.418). The secondary endpoint was achieved by 295 patients, 171 (90.5%) of them treated with P and 124 (91.9%) treated with PI (p=0.669). No significant differences were found between groups treated with P and PI concerning rescue therapy (15 vs. 6 patients; p=0.893). Interestingly, PI was more effective than P in patients with bacterial fever at T1 (P 33.6% vs. PI 48.6%; p=0.040), while efficacy of P and PI was similar at T2 for all kind of fever. CONCLUSIONS: Paracetamol 1,000 mg represents the first choice for the treatment of fever in the ED, followed by Paracetamol/Ibuprofen 500/150 mg. Interestingly, Paracetamol/Ibuprofen combination resulted in being more effective in patients with bacterial fever one hour after its administration. [ABSTRACT FROM AUTHOR]
- Published
- 2023
13. Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases
- Author
-
Candelli, M., Franza, L., Pignataro, G., Ojetti, V., Covino, M., Piccioni, A., Gasbarrini, A., Franceschi, F., Candelli M. (ORCID:0000-0001-8443-7880), Franza L., Pignataro G., Ojetti V. (ORCID:0000-0002-8953-0707), Covino M. (ORCID:0000-0002-6709-2531), Piccioni A., Gasbarrini A. (ORCID:0000-0002-7278-4823), Franceschi F. (ORCID:0000-0001-6266-445X), Candelli, M., Franza, L., Pignataro, G., Ojetti, V., Covino, M., Piccioni, A., Gasbarrini, A., Franceschi, F., Candelli M. (ORCID:0000-0001-8443-7880), Franza L., Pignataro G., Ojetti V. (ORCID:0000-0002-8953-0707), Covino M. (ORCID:0000-0002-6709-2531), Piccioni A., Gasbarrini A. (ORCID:0000-0002-7278-4823), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Lipopolysaccharides (LPSs) are bacterial surface glycolipids, produced by Gram-negative bacteria. LPS is known to determine acute inflammatory reactions, particularly in the context of sepsis. However, LPS can also trigger chronic inflammation. In this case, the source of LPS is not an external infection, but rather an increase in endogenous production, which is usually sustained by gut microbiota (GM), and LPS contained in food. The first site in which LPS can exert its inflammatory action is the gut: both GM and gut-associated lymphoid tissue (GALT) are influenced by LPS and shift towards an inflammatory pattern. The changes in GM and GALT induced by LPS are quite similar to the ones seen in IBD: GM loses diversity, while GALT T regulatory (Tregs) lymphocytes are reduced in number, with an increase in Th17 and Th1 lymphocytes. Additionally, the innate immune system is triggered, through the activation of toll-like receptor (TLR)-4, while the epithelium is directly damaged, further triggering inflammation. In this review, we will discuss the importance of the crosstalk between LPS, GM, and GALT, and discuss the possible implications.
- Published
- 2021
14. The role of early procalcitonin determination in the emergency department in adults hospitalized with fever
- Author
-
Covino, M., Gallo, A., Montalto, M., De Matteis, G., Burzo, M. L., Simeoni, B., Murri, R., Candelli, M., Ojetti, V., Franceschi, F., Covino M. (ORCID:0000-0002-6709-2531), Gallo A., Montalto M. (ORCID:0000-0001-8819-3684), De Matteis G., Simeoni B., Murri R. (ORCID:0000-0003-4263-7854), Candelli M. (ORCID:0000-0001-8443-7880), Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), Covino, M., Gallo, A., Montalto, M., De Matteis, G., Burzo, M. L., Simeoni, B., Murri, R., Candelli, M., Ojetti, V., Franceschi, F., Covino M. (ORCID:0000-0002-6709-2531), Gallo A., Montalto M. (ORCID:0000-0001-8819-3684), De Matteis G., Simeoni B., Murri R. (ORCID:0000-0003-4263-7854), Candelli M. (ORCID:0000-0001-8443-7880), Ojetti V. (ORCID:0000-0002-8953-0707), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Background and Objectives: Fever is one of the most common presenting complaints in the Emergency Department (ED). The role of serum procalcitonin (PCT) determination in the ED evaluation of adults presenting with fever is still debated. The aim of this study was to evaluate if, in adults presenting to the ED with fever and then hospitalized, the early PCT determination could improve prognosis. Materials and Methods. This is a retrospective, mono-centric study, conducted over a 10-year period (2009–2018). We analyzed consecutive patients ≥18 years admitted to ED with fever and then hospitalized. According to quick sequential organ failure assessment (qSOFA) at admission, we compared patients that had a PCT determination vs. controls. Primary endpoint was overall inhospital mortality; secondary endpoints were in-hospital length of stay, and mortality in patients with bloodstream infection and acute respiratory infections. Results. The sample included 12,062 patients, median age was 71 years and 55.1% were men. In patients with qSOFA ≥ 2 overall mortality was significantly lower if they had a PCT-guided management in ED, (20.5% vs. 26.5%; p = 0.046). In the qSOFA > 2 group the mortality was not significantly different in PCT patients, except for those with a final diagnosis of bloodstream infection. Conclusions. Among adults hospitalized with fever, the PCT evaluation at ED admission was not associated with better outcomes, with the possible exception of patients affected by bloodstream infections. However, in febrile patients presenting to the ED with qSOFA ≥ 2, the early PCT evaluation could improve the overall in-hospital survival.
- Published
- 2021
15. Early procalcitonin determination in the emergency department and clinical outcome of community-acquired pneumonia in old and oldest old patients
- Author
-
Covino, M, Piccioni, A, Bonadia, N, Onder, G, Sabia, L, Carbone, L, Candelli, M, Ojetti, V, Murri, R, Franceschi, F., Covino M (ORCID:0000-0002-6709-2531), Piccioni A, Onder G (ORCID:0000-0003-3400-4491), Sabia L, Carbone L, Candelli M (ORCID:0000-0001-8443-7880), Ojetti V (ORCID:0000-0002-8953-0707), Murri R (ORCID:0000-0003-4263-7854), Franceschi F. (ORCID:0000-0001-6266-445X), Covino, M, Piccioni, A, Bonadia, N, Onder, G, Sabia, L, Carbone, L, Candelli, M, Ojetti, V, Murri, R, Franceschi, F., Covino M (ORCID:0000-0002-6709-2531), Piccioni A, Onder G (ORCID:0000-0003-3400-4491), Sabia L, Carbone L, Candelli M (ORCID:0000-0001-8443-7880), Ojetti V (ORCID:0000-0002-8953-0707), Murri R (ORCID:0000-0003-4263-7854), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
We evaluated patients admitted through our ED for community-acquired pneumonia (CAP) to assess the relevance of an early procalcitonin (PCT) determination on patient's outcomes. Methods: We reviewed all patients admitted for CAP in a 10 years period (2008-2017). Patients were stratified according to age groups: (18-65 years; 65-84 years; and ≥85 years), CURB-65 score, need for ventilation, Sepsis-3 criteria at admission, enrollment period, blood culture in ED. In-hospital mortality rate and length of hospital stay (LOS) were compared between patients that had an early PCT determination in ED vs. patients admitted without. Results: Our study cohort consisted of 4056 CAP patients, age 76 [IQ range 64-84] years. We enrolled 1039 patients <65 years old, 2015 aged 65-84 years, and 1002 aged ≥85 years. Overall, the early PCT determination in ED was not associated to a reduced LOS (p=0.630), nor to a reduced mortality rate (p=0.134). However, in patients ≥ 85 years, the PCT determination in ED was associated with lower mortality in those with CURB-65 ≥ 2, and Charlson's score ≥ 2 (p=0.033 and p=0.002, respectively). Conclusions: Although an early PCT assessment in ED was not associated with better outcomes in term of LOS and mortality in patients with CAP, our findings suggest that it might be associated with reduced mortality in patients ≥ 85 years with severe CAP or high comorbidity.
- Published
- 2020
16. Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores
- Author
-
Covino, M., Sandroni, C., Santoro, M., Sabia, L., Simeoni, B., Bocci, M. G., Ojetti, V., Candelli, M., Antonelli, M., Gasbarrini, A., Franceschi, F., Covino M. (ORCID:0000-0002-6709-2531), Sandroni C. (ORCID:0000-0002-8878-2611), Sabia L., Simeoni B., Bocci M. G., Ojetti V. (ORCID:0000-0002-8953-0707), Candelli M. (ORCID:0000-0001-8443-7880), Antonelli M. (ORCID:0000-0003-3007-1670), Gasbarrini A. (ORCID:0000-0002-7278-4823), Franceschi F. (ORCID:0000-0001-6266-445X), Covino, M., Sandroni, C., Santoro, M., Sabia, L., Simeoni, B., Bocci, M. G., Ojetti, V., Candelli, M., Antonelli, M., Gasbarrini, A., Franceschi, F., Covino M. (ORCID:0000-0002-6709-2531), Sandroni C. (ORCID:0000-0002-8878-2611), Sabia L., Simeoni B., Bocci M. G., Ojetti V. (ORCID:0000-0002-8953-0707), Candelli M. (ORCID:0000-0001-8443-7880), Antonelli M. (ORCID:0000-0003-3007-1670), Gasbarrini A. (ORCID:0000-0002-7278-4823), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Aims: To identify the most accurate early warning score (EWS) for predicting an adverse outcome in COVID-19 patients admitted to the emergency department (ED). Methods: In adult consecutive patients admitted (March 1-April 15, 2020) to the ED of a major referral centre for COVID-19, we retrospectively calculated NEWS, NEWS2, NEWS-C, MEWS, qSOFA, and REMS from physiological variables measured on arrival. Sensitivity, specificity, positive (PPV) and negative predictive value (NPV), and the area under the receiver operating characteristic (AUROC) curve of each EWS for predicting admission to the intensive care unit (ICU) and death at 48 h and 7 days were calculated. Results: We included 334 patients (119 [35.6%] females, median age 66 [54-78] years). At 7 days, the rates of ICU admission and death were 56/334 (17%) and 26/334 (7.8%), respectively. NEWS was the most accurate predictor of ICU admission within 7 days (AUROC 0.783 [95% CI, 0.735-0.826]; sensitivity 71.4 [57.8-82.7]%; NPV 93.1 [89.8-95.3]%), while REMS was the most accurate predictor of death within 7 days (AUROC 0.823 [0.778–0.863]; sensitivity 96.1 [80.4-99.9]%; NPV 99.4[96.2–99.9]%). Similar results were observed for ICU admission and death at 48 h. NEWS and REMS were as accurate as the triage system used in our ED. MEWS and qSOFA had the lowest overall accuracy for both outcomes. Conclusion: In our single-centre cohort of COVID-19 patients, NEWS and REMS measured on ED arrival were the most sensitive predictors of 7-day ICU admission or death. EWS could be useful to identify patients with low risk of clinical deterioration.
- Published
- 2020
17. Vitamin-K Antagonists vs. Direct Oral Anticoagulants on Severity of Upper Gastrointestinal Bleeding: A Retrospective Analysis of Italian and UK Data
- Author
-
Brigida, M., Di Caro, S., Petruzziello, C., Saviano, Angela, Riccioni, Maria Elena, Franceschi, Francesco, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Riccioni M. E. (ORCID:0000-0002-9239-4312), Franceschi F. (ORCID:0000-0001-6266-445X), Ojetti V. (ORCID:0000-0002-8953-0707), Brigida, M., Di Caro, S., Petruzziello, C., Saviano, Angela, Riccioni, Maria Elena, Franceschi, Francesco, Ojetti, Veronica, Saviano A. (ORCID:0000-0002-2820-7180), Riccioni M. E. (ORCID:0000-0002-9239-4312), Franceschi F. (ORCID:0000-0001-6266-445X), and Ojetti V. (ORCID:0000-0002-8953-0707)
- Abstract
Background: Gastrointestinal bleeding (GIB) is one of most frequent and significant challenges for emergency physicians and gastroenterologists. Mortality for upper (U) GIB is high, especially in the elderly and comorbid patients. However, there is scant evidence in the literature concerning an assessment of warfarin (VKA) and direct oral anticoagulants (DOACs) in terms of upper gastrointestinal bleeding (UGIB) severity. Aims: Using data from two different settings (Italy and the UK), we aimed to compare the impact of VKA and DOACs on the severity of UGIB. Methods: Retrospective bicentric study on adult patients under VKA or DOACs admitted either to the emergency department at the Gemelli Hospital in Rome, Italy or University College Hospital in London, UK, with suspected UGIB from 01/01/2017 to 31/12/2018. Univariate analysis with Fisher's exact test, and analysis of variance (ANOVA) were used. Results: 106 patients (62 M/44 F; mean age 71.2 +/- 16.9 yrs) were enrolled and divided into the VKA group (N = 57; M: 56%, mean age: 64.9 +/- 21.3 yrs) and the DOAC group (N = 49; M: 61%; mean age: 77.6 +/- 12.5 yrs). At univariate analysis, the VKA group presented two endoscopic diagnoses more frequently than the DOAC group (26% vs. 8%, p < 0.05), were more frequently endoscopically treated (44% vs. 22%, p < 0.05), rescoped (12% vs. 2%, p = 0.048) and hospitalized (79% vs. 53%, p = 0.01) with a longer length of stay, LOS (VKA: 58% > 5 days vs. DOAC: 68% < 5 days, p = 0.01). There was no difference in terms of hemoglobin level on admission, however the requirement of blood transfusions was higher in the VKA group (60% vs. 41%, p = 0.041). One third of the VKA group showed a lower platelet count than the DOAC group (33% vs. 8%, p = 0.01). No statistically significant differences for in-hospital mortality were observed. For the ANOVA, the type of anticoagulant used was the only significant predictor of need to rescope (p = 0.041) and a significant co-predictor for
- Published
- 2022
18. Hip Fracture Risk in Elderly With Non-End-Stage Chronic Kidney Disease: A Fall Related Analysis
- Author
-
Covino, Marcello, Vitiello, Raffaele, De Matteis, Giuseppe, Bonadia, N., Piccioni, Andrea, Carbone, Luigi, Zaccaria, R., Cauteruccio, M., Ojetti, Veronica, Franceschi, Francesco, Covino M. (ORCID:0000-0002-6709-2531), Vitiello R., De Matteis G., Piccioni A., Carbone L., Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), Covino, Marcello, Vitiello, Raffaele, De Matteis, Giuseppe, Bonadia, N., Piccioni, Andrea, Carbone, Luigi, Zaccaria, R., Cauteruccio, M., Ojetti, Veronica, Franceschi, Francesco, Covino M. (ORCID:0000-0002-6709-2531), Vitiello R., De Matteis G., Piccioni A., Carbone L., Ojetti V. (ORCID:0000-0002-8953-0707), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Background: The aim of this study was to evaluate the risk of fracture as a consequence of trauma and its association with kidney function status in a cohort of elderly patients. Methods: This is an observational, cross-sectional study. We evaluated all fall-related trauma of patients ≥ 65 years in the emergency department (ED) between 2016 and 2018. According to CDK-EPI formula, we stratified the study population in different stages of chronic kidney disease (CKD) for glomerular filtrate rate (GFR) ≥ 15 and < 60, not on hemodialysis. The hip fracture rate was adjusted at multivariate analysis for age, sex, comorbid conditions, and CKD status. Results: We enrolled 5620 patients: 3482 patients had GFR ≥60, 1045 had GFR ≥45 and <60, 722 had GFR ≥30 and <45, and 371 had GFR ≥15 and <30. We recorded 636 (11.3%) hip fractures. After adjusting for significant covariates (age, sex, known osteoporosis, osteoporosis therapy, anemia, and dementia), patients with GFR ≥ 45 and <60 and GFR ≥30 and <45 exhibited an increased risk of femur fracture (odds ratio 2.01 [1.36–2.97] and 1.64 [1.08–2.48], respectively). Patients with GFR ≥15 and <30 had a higher risk of fracture, although not reaching statistical significance. Conclusions: Our study confirms that patients with non-end stage CKD have an increased risk of femur fracture after a fall. Our data supports the hypothesis that this risk could be associated with increased bone fragility in CKD patients. Active osteoporosis therapy was found to be an effective preventive factor in our cohort.
- Published
- 2022
19. Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis
- Author
-
Ojetti, Veronica, Saviano, Angela, Brigida, M., Petruzziello, C., Caronna, M., Gayani, G., Franceschi, Francesco, Ojetti V. (ORCID:0000-0002-8953-0707), Saviano A. (ORCID:0000-0002-2820-7180), Franceschi F. (ORCID:0000-0001-6266-445X), Ojetti, Veronica, Saviano, Angela, Brigida, M., Petruzziello, C., Caronna, M., Gayani, G., Franceschi, Francesco, Ojetti V. (ORCID:0000-0002-8953-0707), Saviano A. (ORCID:0000-0002-2820-7180), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Introduction Recent guidelines suggest treating acute uncomplicated diverticulitis (AUD) without antibiotics. We tested the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in AUD. Primary outcome was the reduction of abdominal pain and inflammatory markers [C-reactive protein (C-RP) and calprotectin]. Secondary outcome was the reduction of hours of hospitalization. Patients and methods A double-blind, randomized controlled trial was conducted in 119 patients with AUD. The probiotic group (61 patients) was treated with fluids, bowel rest and L. reuteri/b.i.d. for 10 days. The placebo group (58 patients) was treated with the same therapy and placebo/b.i.d. for 10 days. All patients completed a daily visual analogue scale (VAS) for abdominal pain. Results Both groups showed a mean VAS score of 7 at enrolment and a reduction of 4 points after 3 days. C-RP value, after 72 h, decreased by 58.8% in the probiotic group and by only 40% in the placebo group (P < 0.05). Calprotectin levels, after 72 h, decreased by 17% in the probiotic group and by only 10.6% in the control group (P < 0.05). In the probiotic group, the hospitalization was done for 75.5 h compared to 83.5 in the placebo group. Conclusions The supplementation with L. reuteri 4659 together with bowel rest and fluids significantly reduced both blood and faecal inflammatory markers compared to the placebo group.
- Published
- 2022
20. Nickel Free-Diet Enhances the Helicobacter pylori Eradication Rate: A Pilot Study
- Author
-
Campanale, M., Nucera, E., Ojetti, V., Cesario, V., Di Rienzo, T. A., D’Angelo, G., Pecere, S., Barbaro, F., Gigante, G., De Pasquale, T., Rizzi, A., Cammarota, G., Schiavino, D., Franceschi, F., and Gasbarrini, A.
- Published
- 2014
- Full Text
- View/download PDF
21. cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer
- Author
-
Ojetti, V., Persiani, R., Cananzi, F. C. M., Sensi, C., Piscaglia, A. C., Saulnier, N., Biondi, A., Gasbarrini, A., and D’Ugo, D.
- Published
- 2014
- Full Text
- View/download PDF
22. AF.6 IMPACT OF VITAMIN-K ANTAGONISTS AND DIRECT ORAL ANTICOAGULANTS ON SEVERITY OF UPPER GASTROINTESTINAL BLEEDING: A RETROSPECTIVE ANALYSIS OF ITALIAN AND UK DATA
- Author
-
Brigida, M., primary, Di Caro, S., additional, Petruzziello, C., additional, Riccioni, M.E., additional, Franceschi, F., additional, and Ojetti, V., additional
- Published
- 2021
- Full Text
- View/download PDF
23. Acute obstructive jaundice management in emergency: Management, clinical and patient’s safety considerations regarding the use of the short observation unit
- Author
-
Piccioni, A., Petruziello, C., Perri, V., Costamagna, G., Franceschi, F., Bolcato, M., Trabucco Aurilio, M, and Ojetti, V.
- Subjects
Patient safety ,Clinical risk management ,Healthcare management ,SARS-CoV-2 ,Emergency room - Published
- 2021
24. Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period
- Author
-
Scaldaferri, Franco, Papa, Alfredo, Napolitano, Daniele, Rizzatti, Gianenrico, Pistone, M. T., Poscia, Andrea, Volpe, Massimo, Lopetuso, Loris Riccardo, Schiavoni, Elisa, Guidi, Luisa, Gaetani, Eleonora, Holleran, G., Cammarota, Giovanni, Rapaccini, Gian Ludovico, Pugliese, Daniela, Ojetti, Veronica, Franceschi, Francesco, Armuzzi, Alessandro, Gasbarrini, Antonio, Scaldaferri F. (ORCID:0000-0001-8334-7541), Papa A. (ORCID:0000-0002-4186-7298), Napolitano D., Rizzatti G. (ORCID:0000-0003-1876-7587), Poscia A. (ORCID:0000-0002-7616-3389), Volpe M., Lopetuso L. R., Schiavoni E., Guidi L. (ORCID:0000-0003-3320-7094), Gaetani E. (ORCID:0000-0002-7808-1491), Cammarota G. (ORCID:0000-0002-3626-6148), Rapaccini G. (ORCID:0000-0002-6467-857X), Pugliese D., Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), Armuzzi A. (ORCID:0000-0003-1572-0118), Gasbarrini A. (ORCID:0000-0002-7278-4823), Scaldaferri, Franco, Papa, Alfredo, Napolitano, Daniele, Rizzatti, Gianenrico, Pistone, M. T., Poscia, Andrea, Volpe, Massimo, Lopetuso, Loris Riccardo, Schiavoni, Elisa, Guidi, Luisa, Gaetani, Eleonora, Holleran, G., Cammarota, Giovanni, Rapaccini, Gian Ludovico, Pugliese, Daniela, Ojetti, Veronica, Franceschi, Francesco, Armuzzi, Alessandro, Gasbarrini, Antonio, Scaldaferri F. (ORCID:0000-0001-8334-7541), Papa A. (ORCID:0000-0002-4186-7298), Napolitano D., Rizzatti G. (ORCID:0000-0003-1876-7587), Poscia A. (ORCID:0000-0002-7616-3389), Volpe M., Lopetuso L. R., Schiavoni E., Guidi L. (ORCID:0000-0003-3320-7094), Gaetani E. (ORCID:0000-0002-7808-1491), Cammarota G. (ORCID:0000-0002-3626-6148), Rapaccini G. (ORCID:0000-0002-6467-857X), Pugliese D., Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), Armuzzi A. (ORCID:0000-0003-1572-0118), and Gasbarrini A. (ORCID:0000-0002-7278-4823)
- Abstract
Objective: The management of Inflammatory Bowel Disease (IBD) has changed significantly in recent years, mainly due to the introduction of biologic medications, however, other factors may also have a role. The aim of this study was to evaluate the evolution of IBD admissions, including trends, modality of admission and rates of surgical intervention, in a tertiary care center. Patients and Methods: Hospitalization of patients with a diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) were identified between 2000 and 2013, using ICD-9-CM codes for IBD, from our hospital database. The following parameters were evaluated for each admission: type of admission (ordinary vs. day care service), mode of admission (elective vs. emergency care, for ordinary admissions only), admission code, surgical procedures and complication rates. Comparison between pre- and post-biologic therapy introduction years was also performed. Results: Between 2000 and 2013 a total of 8834 IBD-related admissions were recorded. Hospitalizations increased linearly reaching a peak in 2006, with a downward trend in the following years. The downward trend was especially marked for patients younger than 40 years. No significant differences in hospitalization trends between CD and UC were recorded. Disease flare represented the cause of hospitalization in approximately 50% of cases. Overall, 10.8% of patients underwent surgery with no difference between the two conditions. Complications occurred in 28.7% of admissions. Conclusions: Hospitalizations for IBD patients have decreased in recent years, especially in younger patients. However, a significant proportion of patients are still admitted to complete diagnostic workup, indicating the need to better implement outpatient services. A clear reduction in surgery occurrence over time could not be observed in our study.
- Published
- 2021
25. The 'Crossed Leg Sign' in the Emergency Department (or Tilli's Sign): A New Semiotic Sign for the Early Evaluation of Patients Accessing the Emergency Setting.
- Author
-
Saviano, Angela, Tilli, Pietro, Petruzziello, C, Franceschi, Francesco, Ojetti, Veronica, Saviano A (ORCID:0000-0002-2820-7180), Tilli P, Franceschi F (ORCID:0000-0001-6266-445X), Ojetti V (ORCID:0000-0002-8953-0707), Saviano, Angela, Tilli, Pietro, Petruzziello, C, Franceschi, Francesco, Ojetti, Veronica, Saviano A (ORCID:0000-0002-2820-7180), Tilli P, Franceschi F (ORCID:0000-0001-6266-445X), and Ojetti V (ORCID:0000-0002-8953-0707)
- Abstract
N/A
- Published
- 2021
26. Humoral predictors of malignancy in IPMN: A review of the literature
- Author
-
Nista, Enrico Celestino, Schepis, Tommaso, Candelli, Marcello, Giuli, Lucia, Pignataro, Giulia, Franceschi, Francesco, Gasbarrini, Antonio, Ojetti, Veronica, Nista E. C., Schepis T., Candelli M. (ORCID:0000-0001-8443-7880), Giuli L., Pignataro G., Franceschi F. (ORCID:0000-0001-6266-445X), Gasbarrini A. (ORCID:0000-0002-7278-4823), Ojetti V. (ORCID:0000-0002-8953-0707), Nista, Enrico Celestino, Schepis, Tommaso, Candelli, Marcello, Giuli, Lucia, Pignataro, Giulia, Franceschi, Francesco, Gasbarrini, Antonio, Ojetti, Veronica, Nista E. C., Schepis T., Candelli M. (ORCID:0000-0001-8443-7880), Giuli L., Pignataro G., Franceschi F. (ORCID:0000-0001-6266-445X), Gasbarrini A. (ORCID:0000-0002-7278-4823), and Ojetti V. (ORCID:0000-0002-8953-0707)
- Abstract
Pancreatic cystic lesions are increasingly detected in cross-sectional imaging. Intraductal papillary mucinous neoplasm (IPMN) is a mucin-producing subtype of the pancreatic cyst lesions arising from the pancreatic duct system. IPMN is a potential precursor of pancreatic cancer. The transformation of IPMN in pancreatic cancer is progressive and requires the occurrence of low-grade dysplasia, high-grade dysplasia, and ultimately invasive cancer. Jaundice, enhancing mural nodule >5 mm, main pancreatic duct diameter >10 mm, and positive cytology for high-grade dysplasia are considered high-risk stigmata of malignancy. While increased levels of carbohydrate antigen 19-9 (CA 19-9) (>37 U/mL), main pancreatic duct diameter 5–9.9 mm, cyst diameter >40 mm, enhancing mural nodules <5 mm, IPMN-induced acute pancreatitis, new onset of diabetes, cyst grow-rate >5 mm/year are considered worrisome features of malignancy. However, cross-sectional imaging is often inadequate in the prediction of high-grade dysplasia and invasive cancer. Several studies evaluated the role of humoral and intra-cystic biomarkers in the prediction of malignancy in IPMN. Carcinoembryonic antigen (CEA), CA 19-9, intra-cystic CEA, intra-cystic glucose, and cystic fluid cytology are widely used in clinical practice to distinguish between mucinous and non-mucinous cysts and to predict the presence of invasive cancer. Other biomarkers such as cystic fluid DNA sequencing, microRNA (mi-RNA), circulating microvesicles, and liquid biopsy are the new options for the mini-invasive diagnosis of degenerated IPMN. The aim of this study is to review the literature to assess the role of humoral and intracystic biomarkers in the prediction of advanced IPMN with high-grade dysplasia or invasive carcinoma.
- Published
- 2021
27. A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19
- Author
-
Murri, Rita, Lenkowicz, Jacopo, Masciocchi, Carlotta, Iacomini, C., Fantoni, Massimo, Damiani, Andrea, Marchetti, A., Sergi, P. D. A., Arcuri, G., Cesario, Alfredo, Patarnello, S., Antonelli, Massimo, Bellantone, Rocco Domenico Alfonso, Bernabei, Roberto, Boccia, Stefania, Calabresi, Paolo, Cambieri, Andrea, Cauda, Roberto, Colosimo, Cesare, Crea, Filippo, De Maria Marchiano, Ruggero, De Stefano, Valerio, Franceschi, Francesco, Gasbarrini, Antonio, Parolini, Ornella, Richeldi, Luca, Sanguinetti, Maurizio, Urbani, Andrea, Zega, Maurizio, Scambia, Giovanni, Valentini, Vincenzo, Armuzzi, Alessandro, Barba, Marta, Baroni, Silvia, Bellesi, Silvia, Bentivoglio, Anna Rita, Biasucci, Luigi Marzio, Biscetti, Federico, Candelli, Marcello, Capalbo, Gennaro, Cattani Franchi, Paola, Chiusolo, Patrizia, Cingolani, Antonella, Corbo, Giuseppe Maria, Covino, Marcello, Cozzolino, A. M., D'Alfonso, Maria Elena, De Angelis, Giulia, De Pascale, Gennaro, Frisullo, Giovanni, Gabrielli, M., Gambassi, Giovanni, Garcovich, M., Gremese, Elisa, Grieco, D. L., Iaconelli, A., Iorio, Raffaele, Landi, Francesco, Larici, Anna Rita, Liuzzo, Giovanna, Maviglia, Riccardo, Miele, Luca, Montalto, Massimo, Natale, Luigi, Nicolotti, Nicola, Ojetti, Veronica, Pompili, Maurizio, Posteraro, Brunella, Rapaccini, Gian Ludovico, Rinaldi, R., Rossi, Elena, Santoliquido, Angelo, Sica, Simona, Tamburrini, Enrica, Teofili, Luciana, Testa, Antonia Carla, Tosoni, A., Trani, Carlo, Varone, Francesco, Verme, L. Z. D., Murri R. (ORCID:0000-0003-4263-7854), Lenkowicz J., Masciocchi C., Fantoni M. (ORCID:0000-0001-6913-8460), Damiani A., Cesario A. (ORCID:0000-0003-4687-0709), Antonelli M. (ORCID:0000-0003-3007-1670), Bellantone R. (ORCID:0000-0002-0844-3469), Bernabei R. (ORCID:0000-0002-9197-004X), Boccia S. (ORCID:0000-0002-1864-749X), Calabresi P. (ORCID:0000-0003-0326-5509), Cambieri A., Cauda R. (ORCID:0000-0002-1498-4229), Colosimo C. (ORCID:0000-0003-3800-3648), Crea F. (ORCID:0000-0001-9404-8846), De Maria R. (ORCID:0000-0003-2255-0583), De Stefano V. (ORCID:0000-0002-5178-5827), Franceschi F. (ORCID:0000-0001-6266-445X), Gasbarrini A. (ORCID:0000-0002-7278-4823), Parolini O. (ORCID:0000-0002-5211-6430), Richeldi L. (ORCID:0000-0001-8594-1448), Sanguinetti M. (ORCID:0000-0002-9780-7059), Urbani A. (ORCID:0000-0001-9168-3174), Zega M. (ORCID:0000-0002-7821-2615), Scambia G. (ORCID:0000-0003-2758-1063), Valentini V. (ORCID:0000-0003-4637-6487), Armuzzi A. (ORCID:0000-0003-1572-0118), Barba M. (ORCID:0000-0001-6084-7666), Baroni S. (ORCID:0000-0002-3410-2617), Bellesi S., Bentivoglio A. (ORCID:0000-0002-9663-095X), Biasucci L. M. (ORCID:0000-0002-6921-6497), Biscetti F. (ORCID:0000-0001-7449-657X), Candelli M. (ORCID:0000-0001-8443-7880), Capalbo G., Cattani P. (ORCID:0000-0003-4678-4763), Chiusolo P. (ORCID:0000-0002-1355-1587), Cingolani A. (ORCID:0000-0002-3793-2755), Corbo G. (ORCID:0000-0002-8104-4659), Covino M. (ORCID:0000-0002-6709-2531), D'Alfonso M., De Angelis G. (ORCID:0000-0002-7087-7399), De Pascale G. (ORCID:0000-0002-8255-0676), Frisullo G., Gambassi G. (ORCID:0000-0002-7030-9359), Gremese E. (ORCID:0000-0002-2248-1058), Iorio R. (ORCID:0000-0002-6270-0956), Landi F. (ORCID:0000-0002-3472-1389), Larici A. (ORCID:0000-0002-1882-6244), Liuzzo G. (ORCID:0000-0002-5714-0907), Maviglia R., Miele L. (ORCID:0000-0003-3464-0068), Montalto M. (ORCID:0000-0001-8819-3684), Natale L. (ORCID:0000-0002-7949-5119), Nicolotti N., Ojetti V. (ORCID:0000-0002-8953-0707), Pompili M. (ORCID:0000-0001-6699-7980), Posteraro B. (ORCID:0000-0002-1663-7546), Rapaccini G. (ORCID:0000-0002-6467-857X), Rossi E. (ORCID:0000-0002-7572-9379), Santoliquido A. (ORCID:0000-0003-1539-4017), Sica S. (ORCID:0000-0003-2426-3465), Tamburrini E. (ORCID:0000-0003-4930-426X), Teofili L. (ORCID:0000-0002-7214-1561), Testa A. (ORCID:0000-0003-2217-8726), Trani C. (ORCID:0000-0001-9777-013X), Varone F., Murri, Rita, Lenkowicz, Jacopo, Masciocchi, Carlotta, Iacomini, C., Fantoni, Massimo, Damiani, Andrea, Marchetti, A., Sergi, P. D. A., Arcuri, G., Cesario, Alfredo, Patarnello, S., Antonelli, Massimo, Bellantone, Rocco Domenico Alfonso, Bernabei, Roberto, Boccia, Stefania, Calabresi, Paolo, Cambieri, Andrea, Cauda, Roberto, Colosimo, Cesare, Crea, Filippo, De Maria Marchiano, Ruggero, De Stefano, Valerio, Franceschi, Francesco, Gasbarrini, Antonio, Parolini, Ornella, Richeldi, Luca, Sanguinetti, Maurizio, Urbani, Andrea, Zega, Maurizio, Scambia, Giovanni, Valentini, Vincenzo, Armuzzi, Alessandro, Barba, Marta, Baroni, Silvia, Bellesi, Silvia, Bentivoglio, Anna Rita, Biasucci, Luigi Marzio, Biscetti, Federico, Candelli, Marcello, Capalbo, Gennaro, Cattani Franchi, Paola, Chiusolo, Patrizia, Cingolani, Antonella, Corbo, Giuseppe Maria, Covino, Marcello, Cozzolino, A. M., D'Alfonso, Maria Elena, De Angelis, Giulia, De Pascale, Gennaro, Frisullo, Giovanni, Gabrielli, M., Gambassi, Giovanni, Garcovich, M., Gremese, Elisa, Grieco, D. L., Iaconelli, A., Iorio, Raffaele, Landi, Francesco, Larici, Anna Rita, Liuzzo, Giovanna, Maviglia, Riccardo, Miele, Luca, Montalto, Massimo, Natale, Luigi, Nicolotti, Nicola, Ojetti, Veronica, Pompili, Maurizio, Posteraro, Brunella, Rapaccini, Gian Ludovico, Rinaldi, R., Rossi, Elena, Santoliquido, Angelo, Sica, Simona, Tamburrini, Enrica, Teofili, Luciana, Testa, Antonia Carla, Tosoni, A., Trani, Carlo, Varone, Francesco, Verme, L. Z. D., Murri R. (ORCID:0000-0003-4263-7854), Lenkowicz J., Masciocchi C., Fantoni M. (ORCID:0000-0001-6913-8460), Damiani A., Cesario A. (ORCID:0000-0003-4687-0709), Antonelli M. (ORCID:0000-0003-3007-1670), Bellantone R. (ORCID:0000-0002-0844-3469), Bernabei R. (ORCID:0000-0002-9197-004X), Boccia S. (ORCID:0000-0002-1864-749X), Calabresi P. (ORCID:0000-0003-0326-5509), Cambieri A., Cauda R. (ORCID:0000-0002-1498-4229), Colosimo C. (ORCID:0000-0003-3800-3648), Crea F. (ORCID:0000-0001-9404-8846), De Maria R. (ORCID:0000-0003-2255-0583), De Stefano V. (ORCID:0000-0002-5178-5827), Franceschi F. (ORCID:0000-0001-6266-445X), Gasbarrini A. (ORCID:0000-0002-7278-4823), Parolini O. (ORCID:0000-0002-5211-6430), Richeldi L. (ORCID:0000-0001-8594-1448), Sanguinetti M. (ORCID:0000-0002-9780-7059), Urbani A. (ORCID:0000-0001-9168-3174), Zega M. (ORCID:0000-0002-7821-2615), Scambia G. (ORCID:0000-0003-2758-1063), Valentini V. (ORCID:0000-0003-4637-6487), Armuzzi A. (ORCID:0000-0003-1572-0118), Barba M. (ORCID:0000-0001-6084-7666), Baroni S. (ORCID:0000-0002-3410-2617), Bellesi S., Bentivoglio A. (ORCID:0000-0002-9663-095X), Biasucci L. M. (ORCID:0000-0002-6921-6497), Biscetti F. (ORCID:0000-0001-7449-657X), Candelli M. (ORCID:0000-0001-8443-7880), Capalbo G., Cattani P. (ORCID:0000-0003-4678-4763), Chiusolo P. (ORCID:0000-0002-1355-1587), Cingolani A. (ORCID:0000-0002-3793-2755), Corbo G. (ORCID:0000-0002-8104-4659), Covino M. (ORCID:0000-0002-6709-2531), D'Alfonso M., De Angelis G. (ORCID:0000-0002-7087-7399), De Pascale G. (ORCID:0000-0002-8255-0676), Frisullo G., Gambassi G. (ORCID:0000-0002-7030-9359), Gremese E. (ORCID:0000-0002-2248-1058), Iorio R. (ORCID:0000-0002-6270-0956), Landi F. (ORCID:0000-0002-3472-1389), Larici A. (ORCID:0000-0002-1882-6244), Liuzzo G. (ORCID:0000-0002-5714-0907), Maviglia R., Miele L. (ORCID:0000-0003-3464-0068), Montalto M. (ORCID:0000-0001-8819-3684), Natale L. (ORCID:0000-0002-7949-5119), Nicolotti N., Ojetti V. (ORCID:0000-0002-8953-0707), Pompili M. (ORCID:0000-0001-6699-7980), Posteraro B. (ORCID:0000-0002-1663-7546), Rapaccini G. (ORCID:0000-0002-6467-857X), Rossi E. (ORCID:0000-0002-7572-9379), Santoliquido A. (ORCID:0000-0003-1539-4017), Sica S. (ORCID:0000-0003-2426-3465), Tamburrini E. (ORCID:0000-0003-4930-426X), Teofili L. (ORCID:0000-0002-7214-1561), Testa A. (ORCID:0000-0003-2217-8726), Trani C. (ORCID:0000-0001-9777-013X), and Varone F.
- Abstract
The COVID-19 pandemic is impressively challenging the healthcare system. Several prognostic models have been validated but few of them are implemented in daily practice. The objective of the study was to validate a machine-learning risk prediction model using easy-to-obtain parameters to help to identify patients with COVID-19 who are at higher risk of death. The training cohort included all patients admitted to Fondazione Policlinico Gemelli with COVID-19 from March 5, 2020, to November 5, 2020. Afterward, the model was tested on all patients admitted to the same hospital with COVID-19 from November 6, 2020, to February 5, 2021. The primary outcome was in-hospital case-fatality risk. The out-of-sample performance of the model was estimated from the training set in terms of Area under the Receiving Operator Curve (AUROC) and classification matrix statistics by averaging the results of fivefold cross validation repeated 3-times and comparing the results with those obtained on the test set. An explanation analysis of the model, based on the SHapley Additive exPlanations (SHAP), is also presented. To assess the subsequent time evolution, the change in paO2/FiO2 (P/F) at 48 h after the baseline measurement was plotted against its baseline value. Among the 921 patients included in the training cohort, 120 died (13%). Variables selected for the model were age, platelet count, SpO2, blood urea nitrogen (BUN), hemoglobin, C-reactive protein, neutrophil count, and sodium. The results of the fivefold cross-validation repeated 3-times gave AUROC of 0.87, and statistics of the classification matrix to the Youden index as follows: sensitivity 0.840, specificity 0.774, negative predictive value 0.971. Then, the model was tested on a new population (n = 1463) in which the case-fatality rate was 22.6%. The test model showed AUROC 0.818, sensitivity 0.813, specificity 0.650, negative predictive value 0.922. Considering the first quartile of the predicted risk score (low-risk sc
- Published
- 2021
28. Energy drinks: a narrative review of their physiological and pathological effects
- Author
-
Piccioni, Andrea, Covino, Marcello, Zanza, Christian, Longhitano, Y., Tullo, Gianluca, Bonadia, N., Rinninella, Emanuele, Ojetti, Veronica, Gasbarrini, Antonio, Franceschi, Francesco, Piccioni A., Covino M. (ORCID:0000-0002-6709-2531), Zanza C., Tullo G., Rinninella E. (ORCID:0000-0002-9165-2367), Ojetti V. (ORCID:0000-0002-8953-0707), Gasbarrini A. (ORCID:0000-0002-7278-4823), Franceschi F. (ORCID:0000-0001-6266-445X), Piccioni, Andrea, Covino, Marcello, Zanza, Christian, Longhitano, Y., Tullo, Gianluca, Bonadia, N., Rinninella, Emanuele, Ojetti, Veronica, Gasbarrini, Antonio, Franceschi, Francesco, Piccioni A., Covino M. (ORCID:0000-0002-6709-2531), Zanza C., Tullo G., Rinninella E. (ORCID:0000-0002-9165-2367), Ojetti V. (ORCID:0000-0002-8953-0707), Gasbarrini A. (ORCID:0000-0002-7278-4823), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
The consumption of energy drinks (Edks) has increased significantly in past years, with a growing market that is estimated to reach $61 billion by 2021 worldwide. Several studies demonstrated the physiological and pathological effects of these substances contained in Edks. The most common ingredient contained in Edks is caffeine, which is commonly mixed with taurine, and B-group vitamins. Scientific evidence of potentially serious adverse health effects are known, but it would be better to acquire more information regarding these beverages. We systematically checked Medical literature on MEDLINE-Pubmed from inception to January 2020 to find studies and reports on Edks and adverse events. Edks consumption is specially related to cardiovascular effects as malignant arrhythmias. We found a significant focus on arrhythmogenic risk in patients affected by long QT syndrome or other predisposing conditions for QT elongation. Other pathological effects are known as gastrointestinal, vascular and neurological disorders. Edks, as well as all caffeinated beverages, should be taken with caution or avoided in select populations, such as patients suffering from cardiovascular or neurological illnesses; their use can unmask a sleepy life-threatening disease.
- Published
- 2021
29. 510 Long COVID: Predictive Factors and Prevalence in Population
- Author
-
Novelli, M., Franceschi, F., Rozzi, G., Spaziani, G., Pignataro, G., Tullo, G., Merra, G., Piccioni, A., Ojetti, V., and Candelli, M.
- Published
- 2024
- Full Text
- View/download PDF
30. Role of first aid in the management of acute alcohol intoxication: A narrative review
- Author
-
Piccioni, Andrea, Tarli, Claudia, Cardone, S., Brigida, M., D'Addio, S., Covino, Marcello, Zanza, Christian, Merra, Giuseppe, Ojetti, Veronica, Gasbarrini, Antonio, Addolorato, Giovanni, Franceschi, Francesco, Piccioni A., Tarli C., Covino M. (ORCID:0000-0002-6709-2531), Zanza C., Merra G., Ojetti V. (ORCID:0000-0002-8953-0707), Gasbarrini A. (ORCID:0000-0002-7278-4823), Addolorato G. (ORCID:0000-0002-1522-9946), Franceschi F. (ORCID:0000-0001-6266-445X), Piccioni, Andrea, Tarli, Claudia, Cardone, S., Brigida, M., D'Addio, S., Covino, Marcello, Zanza, Christian, Merra, Giuseppe, Ojetti, Veronica, Gasbarrini, Antonio, Addolorato, Giovanni, Franceschi, Francesco, Piccioni A., Tarli C., Covino M. (ORCID:0000-0002-6709-2531), Zanza C., Merra G., Ojetti V. (ORCID:0000-0002-8953-0707), Gasbarrini A. (ORCID:0000-0002-7278-4823), Addolorato G. (ORCID:0000-0002-1522-9946), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
OBJECTIVE: Acute alcohol intoxication is actually a common admission cause in the Emergency Department and represents an increasing public health burden, in particular among adolescents. It involves possible and significant illness and injury, which can quickly get worse and may need to be managed in the emergency room. MATERIALS AND METHODS: We conducted a narrative review of the literature regarding the effectiveness of first aid role of the Emergency Department setting. RESULTS: This review included eighteen studies about alcohol intoxication management in the Emergency Department; most of all highlights the emerging phenomenon in Europe and around the world of acute alcohol intoxication management in first aid. The treatment of acute alcohol intoxication depends on general clinical conditions of the patient, vital signs, hemodynamic stability, cognitive state, alcohol-related complications, which are closely related to the blood alcohol concentration. At the same time, symptoms could be extremely variable due to individual differences in alcohol metabolism. In case of mild-moderate intoxication (blood alcohol concentration < 1 g/L), no drugs are necessary. In case of severe intoxication (blood alcohol concentration > 1 g/L), it is necessary to support with intravenous fluids, treat hypoglycemia, hypotension, hypothermia and electrolyte imbalance, administer complex B and C vitamins and accelerate alcohol elimination from blood with metadoxine. Unlike adults, adolescents are more exposed to the toxic effect of alcohol (because of their immature hepatic alcohol dehydrogenase activity), and then, acute alcohol-related complications are more frequent and dangerous in young people than in adult population. In many cases, patients affected by acute alcohol intoxication referring to an Emergency Department have mild-moderate transitory symptoms that do not require the use of drugs; they can benefit from a clinical observation, with a clinical course often complet
- Published
- 2020
31. Atypical presentation of acute pancreatitis: a single center case-match analysis of clinical outcomes
- Author
-
Covino, Marcello, Quero, Giuseppe, Ojetti, Veronica, Cina, C, Galiandro, F, Longo, Fabio, Torelli, E, Fiorillo, Claudio, Menghi, Roberta, Simeoni, B, Franceschi, Francesco, Alfieri, Sergio, Covino M (ORCID:0000-0002-6709-2531), Quero G (ORCID:0000-0002-0001-9479), Ojetti V (ORCID:0000-0002-8953-0707), Longo F, Fiorillo C (ORCID:0000-0001-7681-3567), Menghi R, Franceschi F (ORCID:0000-0001-6266-445X), Alfieri S (ORCID:0000-0002-0404-724X), Covino, Marcello, Quero, Giuseppe, Ojetti, Veronica, Cina, C, Galiandro, F, Longo, Fabio, Torelli, E, Fiorillo, Claudio, Menghi, Roberta, Simeoni, B, Franceschi, Francesco, Alfieri, Sergio, Covino M (ORCID:0000-0002-6709-2531), Quero G (ORCID:0000-0002-0001-9479), Ojetti V (ORCID:0000-0002-8953-0707), Longo F, Fiorillo C (ORCID:0000-0001-7681-3567), Menghi R, Franceschi F (ORCID:0000-0001-6266-445X), and Alfieri S (ORCID:0000-0002-0404-724X)
- Abstract
Objective: Acute pancreatitis (AP) may present an aspecific clinical picture without abdominal symptoms (atypical AP). We compared clinical outcomes between typical and atypical AP. Patients and methods: Thirty out of 1163 patients (2.6%) presented an atypical AP. Demographic, clinical data, laboratory and radiological findings, management type, length of hospital stay (LOS) and mortality rate were retrospectively reviewed. A case match analysis 2:1 was performed. The final groups comprised 50 typical APs (TAP group) and 25 atypical APs (AAP group). Results: The AAP patients presented fever (36%), syncope (32%) and dyspnea (16%) as the most frequent symptoms. Laboratory values showed similarity between the two groups. We noted a comparable edematous AP rate in both groups (p=0.36). Ten (20%) TAP and 3 (12%) AAP patients needed ERCP, respectively (p=0.38). Cholecystectomy was similarly performed in both cohorts (p=0.81). One TAP patient underwent a percutaneous drainage and subsequent surgical necrosectomy compared to none in the AAP cohort (p=0.47). LOS and mortality rate were comparable (p=0.76 and 0.3, respectively). Conclusions: Similar outcomes have been reached in the two groups. Routine evaluation of the serum amylase values fundamentally contributed to early diagnosis and appropriate treatment.
- Published
- 2020
32. Role of troponin in COVID-19 pandemic: A review of literature
- Author
-
Piccioni, Andrea, Brigida, M., Loria, Valentina, Zanza, Christian, Longhitano, Y., Zaccaria, R., Racco, S., Gasbarrini, Antonio, Ojetti, Veronica, Franceschi, Francesco, Candelli, Marcello, Piccioni A., Loria V., Zanza C., Gasbarrini A. (ORCID:0000-0002-7278-4823), Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), Candelli M. (ORCID:0000-0001-8443-7880), Piccioni, Andrea, Brigida, M., Loria, Valentina, Zanza, Christian, Longhitano, Y., Zaccaria, R., Racco, S., Gasbarrini, Antonio, Ojetti, Veronica, Franceschi, Francesco, Candelli, Marcello, Piccioni A., Loria V., Zanza C., Gasbarrini A. (ORCID:0000-0002-7278-4823), Ojetti V. (ORCID:0000-0002-8953-0707), Franceschi F. (ORCID:0000-0001-6266-445X), and Candelli M. (ORCID:0000-0001-8443-7880)
- Abstract
Acute SARS-CoV-2 respiratory disease is an infectious respiratory disease caused by the virus SARS-CoV-2 belonging to the coronaviridae family. A pandemic is still present as of May 2020. In addition to causing pneumonia, SARS-CoV-2 may induce a direct damage to the heart, causing myocarditis, with significant impairment of cardiac contractility, and/or pericarditis. Elderly patients and those with cardiovascular risk factors, such as hypertension and diabetes mellitus, are at increased risk of heart complications from COVID-19. In this review, we focused on the correlation between COVID-19 infection and the high sensitivity troponin T and I, and their significance in the development of myocarditis. Data emerging from the studies so far conducted indicate that a high value of high-sensitivity troponin represents a negative prognostic indicator when associated with heart damage on an infectious-inflammatory basis (i.e. myopericarditis). We should identify a safe and clear diagnostic algorithm, possibly combining patient clinical history, troponin levels and cardiac ultrasound findings that could help us in the prediction of myopericarditis.
- Published
- 2020
33. Rapid clinical management of leishmaniasis in emergency department: A case report with clinical review of recent literature
- Author
-
Piccioni, Andrea, Valletta, Federico, Zanza, Christian, Longhitano, Y., Torelli, E., De Cunzo, Tommaso, Esperide, Alessandra, Brigida, M., Ojetti, Veronica, Covino, Marcello, Taurone, S., Ralli, M., Artico, M., Franceschi, Francesco, Piccioni A., Valletta F., Zanza C., de Cunzo T., Esperide A., Ojetti V. (ORCID:0000-0002-8953-0707), Covino M. (ORCID:0000-0002-6709-2531), Franceschi F. (ORCID:0000-0001-6266-445X), Piccioni, Andrea, Valletta, Federico, Zanza, Christian, Longhitano, Y., Torelli, E., De Cunzo, Tommaso, Esperide, Alessandra, Brigida, M., Ojetti, Veronica, Covino, Marcello, Taurone, S., Ralli, M., Artico, M., Franceschi, Francesco, Piccioni A., Valletta F., Zanza C., de Cunzo T., Esperide A., Ojetti V. (ORCID:0000-0002-8953-0707), Covino M. (ORCID:0000-0002-6709-2531), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Systemic or localized lympho-adenomegaly is a common cause of access to the emergency department (ED), and differential diagnosis is often complicated. The combination of anamnesis, physical examination, laboratory tests, and instrumental diagnosis are extremely important to orientate toward a rapid and correct therapy, even if a prompt discrimination of the etiology of this lymphadenomegaly is not often possible. Our aim with this review is to improve the management of a differential diagnosis between hematological and infective diseases as leishmaniasis in ED and suggest quick diagnostic techniques that might be useful for early identification. Together in the review, we describe a case report of a young man affected from visceral leishmaniasis who presented to our ED and was incorrectly addressed to the wrong ward for the study of his condition. Subsequently, we focus on the clinical presentation of visceral leishmaniasis and compare it to the most common differential diagnoses that are usually taken into account in the management of such patients.
- Published
- 2020
34. Risk factors for bloodstream infections in gynecological cancer
- Author
-
Franza, Laura, Costantini, Barbara, Corrado, G., Spanu, Teresa, Covino, Marcello, Ojetti, Veronica, Quagliozzi, L., Biscione, A., Taccari, F., Fagotti, Anna, Scambia, Giovanni, Tamburrini, Enrica, Franza L., Costantini B., Spanu T. (ORCID:0000-0003-1864-5184), Covino M. (ORCID:0000-0002-6709-2531), Ojetti V. (ORCID:0000-0002-8953-0707), Fagotti A. (ORCID:0000-0001-5579-335X), Scambia G. (ORCID:0000-0003-2758-1063), Tamburrini E. (ORCID:0000-0003-4930-426X), Franza, Laura, Costantini, Barbara, Corrado, G., Spanu, Teresa, Covino, Marcello, Ojetti, Veronica, Quagliozzi, L., Biscione, A., Taccari, F., Fagotti, Anna, Scambia, Giovanni, Tamburrini, Enrica, Franza L., Costantini B., Spanu T. (ORCID:0000-0003-1864-5184), Covino M. (ORCID:0000-0002-6709-2531), Ojetti V. (ORCID:0000-0002-8953-0707), Fagotti A. (ORCID:0000-0001-5579-335X), Scambia G. (ORCID:0000-0003-2758-1063), and Tamburrini E. (ORCID:0000-0003-4930-426X)
- Abstract
Infections are a threat to frail patients as they have a higher risk of developing serious complications from bloodstream pathogens. The aim of this study was to determine which factors can predict or diagnose bloodstream infections in patients with an underlying gynecologic malignancy. Materials and Methods Between July 2016 and December 2017, 68 patients visiting the emergency room with an underlying gynecologic malignancy were evaluated. Variables concerning underlying disease, invasive procedures, and laboratory and clinical parameters were analyzed. Patients were divided into three groups based on their blood and urine specimens (positive blood specimens, positive urine specimens, and no positive specimens; patients who had both positive blood and urine specimens were included in the group of positive blood specimens). Risk factors for surgical site infections, recent (<30 days) surgery, and chemotherapy were studied separately. Results 68 patients were included in the analysis. Mean age was 55.6 years (standard deviation 14.1). 44% of patients had ovarian cancer, 35% cervical cancer, 12% endometrial cancer, and 9% had other cancer types. In total, 96% of all patients had undergone surgery. Patients who had been treated with chemotherapy were at a higher risk of developing bloodstream infection (P=0.04; odds ratio (OR)=7.9). C reactive protein, bilirubin, and oxygen saturation (SO 2) were significantly different between patients with an underlying infection and those who had none. Only C reactive protein maintained its significance in a linear model, with a cut-off of 180 mg/L (linear regression, P=0.03; OR=4). Conclusions Chemotherapy is a risk factor for the development of bloodstream infections in patients with an underlying gynecologic malignancy; C reactive protein could be a useful tool in making this diagnosis.
- Published
- 2020
35. Assessment of neurological manifestations in hospitalized patients with COVID-19
- Author
-
Luigetti, Marco, Iorio, Raffaele, Bentivoglio, Anna Rita, Tricoli, Luca, Riso, Vittorio, Marotta, Jessica, Piano, Carla, Primiano, Guido Alessandro, Zileri Del Verme, L., Lo Monaco, Maria Rita, Calabresi, Paolo, Abbate, V., Acampora, N., Addolorato, G., Agostini, F., Ainora, M. E., Akacha, K., Amato, E., Andreani, F., Andriollo, G., Annetta, Maria Giuseppina, Annicchiarico, B. E., Antonelli, Massimo, Antonucci, G., Anzellotti, G. M., Armuzzi, A., Baldi, F., Barattucci, I., Barillaro, C., Barone, F., Bellantone, R. D. A., Bellieni, A., Bello, G., Benicchi, A., Benvenuto, F., Berardini, L., Berloco, F., Bernabei, R., Bianchi, A., Biasucci, D. G., Biasucci, L. M., Bibbo, S., Bini, A., Bisanti, A., Biscetti, F., Bocci, M. G., Bonadia, N., Bongiovanni, F., Borghetti, A., Bosco, G., Bosello, Silvia Laura, Bove, V., Bramato, G., Brandi, V., Bruni, T., Bruno, C., Bruno, D., Bungaro, M. C., Buonomo, A., Burzo, L., Calabrese, A., Calvello, M. R., Cambieri, A., Cambise, C., Camma, G., Candelli, M., Canistro, G., Cantanale, A., Capalbo, G., Capaldi, L., Capone, E., Capristo, E., Carbone, L., Cardone, S., Carelli, S., Carfi, A., Carnicelli, A., Caruso, C., Casciaro, F. A., Catalano, L., Cauda, R., Cecchini, A. L., Cerrito, L., Cesarano, M., Chiarito, A., Cianci, Rossella, Cicchinelli, S., Ciccullo, A., Cicetti, M., Ciciarello, F., Cingolani, A., Cipriani, M. C., Consalvo, M. L., Coppola, G., Corbo, G. M., Corsello, A., Costante, F., Costanzi, M., Covino, M., Crupi, D., Cutuli, S. L., D'Addio, S., D'Alessandro, A., D'Alfonso, M. E., D'Angelo, E., D'Aversa, F., Damiano, F., De Berardinis, G. M., De Cunzo, T., De Gaetano, D. K., De Luca, G., De Matteis, G., De Pascale, G., De Santis, P., De Siena, M., De Vito, F., Del Gatto, V., Del Giacomo, P., Del Zompo, F., Dell'Anna, A. M., Della, P. D., Di Gialleonardo, L., Di Giambenedetto, S., Di Luca, R., Di Maurizio, L., Di Muro, M., Dusina, A., Eleuteri, D., Esperide, A., Fachechi, D., Faliero, D., Falsiroli, C., Fantoni, M., Fedele, A., Feliciani, D., Ferrante, C., Ferrone, G., Festa, R., Fiore, M. C., Flex, A., Forte, E., Franceschi, Francesco, Francesconi, A., Franza, L., Funaro, B., Fuorlo, M., Fusco, D., Gabrielli, M., Gaetani, E., Galletta, C., Gallo, A., Gambassi, G., Garcovich, M., Gasbarrini, A., Gasparrini, I., Gelli, S., Giampietro, A., Gigante, L., Giuliano, G., Giupponi, B., Gremese, E., Grieco, Domenico Luca, Guerrera, M., Guglielmi, V., Guidone, C., Gulli, A., Iaconelli, A., Iafrati, A., Ianiro, Gianluca, Iaquinta, A., Impagnatiello, M., Inchingolo, R., Intini, E., Iorio, R., Izzi, I. M., Jovanovic, T., Kadhim, C., La Macchia, R., La Milia, D. I., Landi, F., Landi, G., Landi, R., Landolfi, R., Leo, M., Leone, P. M., Levantesi, L., Liguori, A., Liperoti, R., Lizzio, M. M., Lo Monaco Maria, R., Locantore, P., Lombardi, F., Lombardi, G., Lopetuso, L., Loria, V., Losito, A. R., Lucia, M. B. P., Macagno, F., Macerola, N., Maggi, G., Maiuro, G., Mancarella, F., Mangiola, F., Manno, A., Marchesini, D., Maresca, G. M., Marrone, G., Martis, I., Martone, A. M., Marzetti, Emanuele, Mattana, C., Matteo, M. V., Maviglia, R., Mazzarella, A., Memoli, C., Miele, Luca, Migneco, A., Mignini, I., Milani, A., Milardi, D., Montalto, M., Montemurro, G., Monti, F., Montini, Luca, Morena, T. C., Morra, V., Morretta, C., Moschese, D., Murace, C. A., Murdolo, M., Murri, Rita, Napoli, M., Nardella, E., Natalello, G., Natalini, D., Navarra, S. M., Nesci, A., Nicoletti, A., Nicoletti, R., Nicoletti, T. F., Nicolo, R., Nicolotti, N., Nista, E. C., Nuzzo, E., Oggiano, M., Ojetti, V., Pagano, F. C., Paiano, G., Pais, C., Pallavicini, F., Palombo, A., Paolillo, F., Papa, Alfredo, Papanice, D., Papparella, L. G., Paratore, M., Parrinello, G., Pasciuto, G., Pasculli, P., Pecorini, G., Perniola, S., Pero, E., Petricca, L., Petrucci, M., Picarelli, C., Piccioni, A., Piccolo, A., Piervincenzi, E., Pignataro, G., Pignataro, R., Pintaudi, G., Pisapia, L., Pizzoferrato, M., Pizzolante, F., Pola, R., Policola, C., Pompili, M., Pontecorvi, F., Pontecorvi, V., Ponziani, F., Popolla, V., Porceddu, E., Porfidia, A., Porro, L. M., Potenza, A., Pozzana, F., Privitera, G., Pugliese, D., Pulcini, G., Racco, S., Raffaelli, F., Ramunno, V., Rapaccini, G. L., Richeldi, Luca, Rinninella, Emanuele, Rocchi, S., Romano, B., Romano, S., Rosa, F., Rossi, L., Rossi, R., Rossini, E., Rota, E., Rovedi, F., Rubino, C., Rumi, G., Russo, A., Sabia, L., Salerno, A., Salini, S., Salvatore, L., Samori, D., Sandroni, Claudio, Sanguinetti, M., Santarelli, L., Santini, P., Santolamazza, D., Santoliquido, A., Santopaolo, F., Santoro, M. C., Sardeo, F., Sarnari, C., Saviano, A., Saviano, L., Scaldaferri, Franco, Scarascia, R., Schepis, T., Schiavello, F., Scoppettuolo, G., Sedda, D., Sessa, F., Sestito, L., Settanni, C., Siciliano, M., Siciliano, V., Sicuranza, R., Simeoni, B., Simonetti, J., Smargiassi, A., Soave, P. M., Sonnino, C., Staiti, D., Stella, C., Stella, L., Stival, E., Taddei, E., Talerico, R., Tamburello, E., Tamburrini, E., Tanzarella, E. S., Tarascio, E., Tarli, C., Tersali, A., Tilli, P., Timpano, J., Torelli, E., Torrini, F., Tosato, M., Tosoni, A., Tricoli, L., Tritto, M., Tumbarello, M., Tummolo, A. M., Vallecoccia, M. S., Valletta, F., Varone, F., Vassalli, F., Ventura, G., Verardi, L., Vetrone, L., Vetrugno, G., Visconti, E., Visconti, F., Viviani, A., Zaccaria, R., Zaccone, C., Zelano, L., Zileri Dal Verme, L., Zuccala, G., Luigetti M. (ORCID:0000-0001-7539-505X), Iorio R. (ORCID:0000-0002-6270-0956), Bentivoglio A. R. (ORCID:0000-0002-9663-095X), Tricoli L., Riso V., Marotta J., Piano C., Primiano G., Lo Monaco M. R. (ORCID:0000-0002-1457-7981), Calabresi P. (ORCID:0000-0003-0326-5509), Annetta M. G. (ORCID:0000-0001-7574-1311), Antonelli M. (ORCID:0000-0003-3007-1670), Bosello S. (ORCID:0000-0002-4837-447X), Cianci R. (ORCID:0000-0001-5378-8442), Franceschi F. (ORCID:0000-0001-6266-445X), Grieco D. L. (ORCID:0000-0002-4557-6308), Ianiro G. (ORCID:0000-0002-8318-0515), Marzetti E. (ORCID:0000-0001-9567-6983), Miele L. (ORCID:0000-0003-3464-0068), Montini L. (ORCID:0000-0003-4602-5134), Murri R. (ORCID:0000-0003-4263-7854), Papa A. (ORCID:0000-0002-4186-7298), Richeldi L. (ORCID:0000-0001-8594-1448), Rinninella E. (ORCID:0000-0002-9165-2367), Sandroni C. (ORCID:0000-0002-8878-2611), Scaldaferri F. (ORCID:0000-0001-8334-7541), Luigetti, Marco, Iorio, Raffaele, Bentivoglio, Anna Rita, Tricoli, Luca, Riso, Vittorio, Marotta, Jessica, Piano, Carla, Primiano, Guido Alessandro, Zileri Del Verme, L., Lo Monaco, Maria Rita, Calabresi, Paolo, Abbate, V., Acampora, N., Addolorato, G., Agostini, F., Ainora, M. E., Akacha, K., Amato, E., Andreani, F., Andriollo, G., Annetta, Maria Giuseppina, Annicchiarico, B. E., Antonelli, Massimo, Antonucci, G., Anzellotti, G. M., Armuzzi, A., Baldi, F., Barattucci, I., Barillaro, C., Barone, F., Bellantone, R. D. A., Bellieni, A., Bello, G., Benicchi, A., Benvenuto, F., Berardini, L., Berloco, F., Bernabei, R., Bianchi, A., Biasucci, D. G., Biasucci, L. M., Bibbo, S., Bini, A., Bisanti, A., Biscetti, F., Bocci, M. G., Bonadia, N., Bongiovanni, F., Borghetti, A., Bosco, G., Bosello, Silvia Laura, Bove, V., Bramato, G., Brandi, V., Bruni, T., Bruno, C., Bruno, D., Bungaro, M. C., Buonomo, A., Burzo, L., Calabrese, A., Calvello, M. R., Cambieri, A., Cambise, C., Camma, G., Candelli, M., Canistro, G., Cantanale, A., Capalbo, G., Capaldi, L., Capone, E., Capristo, E., Carbone, L., Cardone, S., Carelli, S., Carfi, A., Carnicelli, A., Caruso, C., Casciaro, F. A., Catalano, L., Cauda, R., Cecchini, A. L., Cerrito, L., Cesarano, M., Chiarito, A., Cianci, Rossella, Cicchinelli, S., Ciccullo, A., Cicetti, M., Ciciarello, F., Cingolani, A., Cipriani, M. C., Consalvo, M. L., Coppola, G., Corbo, G. M., Corsello, A., Costante, F., Costanzi, M., Covino, M., Crupi, D., Cutuli, S. L., D'Addio, S., D'Alessandro, A., D'Alfonso, M. E., D'Angelo, E., D'Aversa, F., Damiano, F., De Berardinis, G. M., De Cunzo, T., De Gaetano, D. K., De Luca, G., De Matteis, G., De Pascale, G., De Santis, P., De Siena, M., De Vito, F., Del Gatto, V., Del Giacomo, P., Del Zompo, F., Dell'Anna, A. M., Della, P. D., Di Gialleonardo, L., Di Giambenedetto, S., Di Luca, R., Di Maurizio, L., Di Muro, M., Dusina, A., Eleuteri, D., Esperide, A., Fachechi, D., Faliero, D., Falsiroli, C., Fantoni, M., Fedele, A., Feliciani, D., Ferrante, C., Ferrone, G., Festa, R., Fiore, M. C., Flex, A., Forte, E., Franceschi, Francesco, Francesconi, A., Franza, L., Funaro, B., Fuorlo, M., Fusco, D., Gabrielli, M., Gaetani, E., Galletta, C., Gallo, A., Gambassi, G., Garcovich, M., Gasbarrini, A., Gasparrini, I., Gelli, S., Giampietro, A., Gigante, L., Giuliano, G., Giupponi, B., Gremese, E., Grieco, Domenico Luca, Guerrera, M., Guglielmi, V., Guidone, C., Gulli, A., Iaconelli, A., Iafrati, A., Ianiro, Gianluca, Iaquinta, A., Impagnatiello, M., Inchingolo, R., Intini, E., Iorio, R., Izzi, I. M., Jovanovic, T., Kadhim, C., La Macchia, R., La Milia, D. I., Landi, F., Landi, G., Landi, R., Landolfi, R., Leo, M., Leone, P. M., Levantesi, L., Liguori, A., Liperoti, R., Lizzio, M. M., Lo Monaco Maria, R., Locantore, P., Lombardi, F., Lombardi, G., Lopetuso, L., Loria, V., Losito, A. R., Lucia, M. B. P., Macagno, F., Macerola, N., Maggi, G., Maiuro, G., Mancarella, F., Mangiola, F., Manno, A., Marchesini, D., Maresca, G. M., Marrone, G., Martis, I., Martone, A. M., Marzetti, Emanuele, Mattana, C., Matteo, M. V., Maviglia, R., Mazzarella, A., Memoli, C., Miele, Luca, Migneco, A., Mignini, I., Milani, A., Milardi, D., Montalto, M., Montemurro, G., Monti, F., Montini, Luca, Morena, T. C., Morra, V., Morretta, C., Moschese, D., Murace, C. A., Murdolo, M., Murri, Rita, Napoli, M., Nardella, E., Natalello, G., Natalini, D., Navarra, S. M., Nesci, A., Nicoletti, A., Nicoletti, R., Nicoletti, T. F., Nicolo, R., Nicolotti, N., Nista, E. C., Nuzzo, E., Oggiano, M., Ojetti, V., Pagano, F. C., Paiano, G., Pais, C., Pallavicini, F., Palombo, A., Paolillo, F., Papa, Alfredo, Papanice, D., Papparella, L. G., Paratore, M., Parrinello, G., Pasciuto, G., Pasculli, P., Pecorini, G., Perniola, S., Pero, E., Petricca, L., Petrucci, M., Picarelli, C., Piccioni, A., Piccolo, A., Piervincenzi, E., Pignataro, G., Pignataro, R., Pintaudi, G., Pisapia, L., Pizzoferrato, M., Pizzolante, F., Pola, R., Policola, C., Pompili, M., Pontecorvi, F., Pontecorvi, V., Ponziani, F., Popolla, V., Porceddu, E., Porfidia, A., Porro, L. M., Potenza, A., Pozzana, F., Privitera, G., Pugliese, D., Pulcini, G., Racco, S., Raffaelli, F., Ramunno, V., Rapaccini, G. L., Richeldi, Luca, Rinninella, Emanuele, Rocchi, S., Romano, B., Romano, S., Rosa, F., Rossi, L., Rossi, R., Rossini, E., Rota, E., Rovedi, F., Rubino, C., Rumi, G., Russo, A., Sabia, L., Salerno, A., Salini, S., Salvatore, L., Samori, D., Sandroni, Claudio, Sanguinetti, M., Santarelli, L., Santini, P., Santolamazza, D., Santoliquido, A., Santopaolo, F., Santoro, M. C., Sardeo, F., Sarnari, C., Saviano, A., Saviano, L., Scaldaferri, Franco, Scarascia, R., Schepis, T., Schiavello, F., Scoppettuolo, G., Sedda, D., Sessa, F., Sestito, L., Settanni, C., Siciliano, M., Siciliano, V., Sicuranza, R., Simeoni, B., Simonetti, J., Smargiassi, A., Soave, P. M., Sonnino, C., Staiti, D., Stella, C., Stella, L., Stival, E., Taddei, E., Talerico, R., Tamburello, E., Tamburrini, E., Tanzarella, E. S., Tarascio, E., Tarli, C., Tersali, A., Tilli, P., Timpano, J., Torelli, E., Torrini, F., Tosato, M., Tosoni, A., Tricoli, L., Tritto, M., Tumbarello, M., Tummolo, A. M., Vallecoccia, M. S., Valletta, F., Varone, F., Vassalli, F., Ventura, G., Verardi, L., Vetrone, L., Vetrugno, G., Visconti, E., Visconti, F., Viviani, A., Zaccaria, R., Zaccone, C., Zelano, L., Zileri Dal Verme, L., Zuccala, G., Luigetti M. (ORCID:0000-0001-7539-505X), Iorio R. (ORCID:0000-0002-6270-0956), Bentivoglio A. R. (ORCID:0000-0002-9663-095X), Tricoli L., Riso V., Marotta J., Piano C., Primiano G., Lo Monaco M. R. (ORCID:0000-0002-1457-7981), Calabresi P. (ORCID:0000-0003-0326-5509), Annetta M. G. (ORCID:0000-0001-7574-1311), Antonelli M. (ORCID:0000-0003-3007-1670), Bosello S. (ORCID:0000-0002-4837-447X), Cianci R. (ORCID:0000-0001-5378-8442), Franceschi F. (ORCID:0000-0001-6266-445X), Grieco D. L. (ORCID:0000-0002-4557-6308), Ianiro G. (ORCID:0000-0002-8318-0515), Marzetti E. (ORCID:0000-0001-9567-6983), Miele L. (ORCID:0000-0003-3464-0068), Montini L. (ORCID:0000-0003-4602-5134), Murri R. (ORCID:0000-0003-4263-7854), Papa A. (ORCID:0000-0002-4186-7298), Richeldi L. (ORCID:0000-0001-8594-1448), Rinninella E. (ORCID:0000-0002-9165-2367), Sandroni C. (ORCID:0000-0002-8878-2611), and Scaldaferri F. (ORCID:0000-0001-8334-7541)
- Abstract
Background and purpose: The objective of this study was to assess the neurological manifestations in a series of consecutive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients, comparing their frequency with a population hospitalized in the same period for flu/respiratory symptoms, finally not related to SARS-CoV-2. Methods: Patients with flu/respiratory symptoms admitted to Fondazione Policlinico Gemelli hospital from 14 March 2020 to 20 April 2020 were retrospectively enrolled. The frequency of neurological manifestations of patients with SARS-CoV-2 infection was compared with a control group. Results: In all, 213 patients were found to be positive for SARS-CoV-2, after reverse transcriptase polymerase chain reaction on nasal or throat swabs, whilst 218 patients were found to be negative and were used as a control group. Regarding central nervous system manifestations, in SARS-CoV-2-positive patients a higher frequency of headache, hyposmia and encephalopathy always related to systemic conditions (fever or hypoxia) was observed. Furthermore, muscular involvement was more frequent in SARS-CoV-2 infection. Conclusions: Patients with COVID-19 commonly have neurological manifestations but only hyposmia and muscle involvement seem more frequent compared with other flu diseases.
- Published
- 2020
36. Acute uncomplicated diverticulitis: key points for early management. A single-centre retrospective study
- Author
-
Pecere, S., Gibiino, G., La Milia, D. I., Bertè, G., Burrelli Scotti, G., Petruzziello, C., Minordi, L. M., Manfredi, R., Franceschi, F., Ojetti, V., Gasbarrini, A., S. Pecere, G. Gibiino, D. I. La Milia, C. Petruzziello, L. M. Minordi, R. Manfredi (ORCID:0000-0002-4972-9500), F. Franceschi (ORCID:0000-0001-6266-445X), V. Ojetti (ORCID:0000-0002-8953-0707), A. Gasbarrini (ORCID:0000-0002-7278-4823), Pecere, S., Gibiino, G., La Milia, D. I., Bertè, G., Burrelli Scotti, G., Petruzziello, C., Minordi, L. M., Manfredi, R., Franceschi, F., Ojetti, V., Gasbarrini, A., S. Pecere, G. Gibiino, D. I. La Milia, C. Petruzziello, L. M. Minordi, R. Manfredi (ORCID:0000-0002-4972-9500), F. Franceschi (ORCID:0000-0001-6266-445X), V. Ojetti (ORCID:0000-0002-8953-0707), and A. Gasbarrini (ORCID:0000-0002-7278-4823)
- Abstract
OBJECTIVE: Acute uncomplicated diverticulitis is an important clinical condition usually managed in clinical practice with antibiotic therapies and hospitalization in ward. In this setting, recent papers and guidelines suggest to limit the use of antibiotics in selected cases and encourage an early discharge in low-risk patients. The purpose of this retrospective study is to identify serological inflammatory markers and CT findings of acute uncomplicated diverticulitis (AUD) at the onset of the disease and the correlation with the need for in-patient or out-patient management. PATIENTS AND METHODS: It was used a database drawn from the collection of the patients admitted to our Emergency Room from January 2016 to 2019 and undergoing urgent abdominal CT-scan for suspicious of acute diverticulitis. For each patient we considered biochemical and radiological parameters at the onset of the disease and if patients were managed as in-patients (hospitalization in ward) or as out-patient (early discharged or after observation in Short Stay Unit). RESULTS: Among patients with early diagnosis of AUD, 108 (65%) were hospitalized in ward with mean time of in-stay of 6.94 days, while only 58 (35%) patients with same diagnosis were managed as out-patient and early discharged from emergency room or after observation in short stay unit with a mean time of in-stay significantly shorter (3.39 days, p-value 0.0007). Higher levels of C reactive protein and the length of colon involved considered as percentage (%) in comparison with the entire colon were significantly related to the need for hospitalization (p-value 0.03). CONCLUSIONS: Biochemical parameters and a more advanced radiological evaluation, as the length (%) of colon involved, could allow a stratification of patients with diagnosis of AUD at the admission and help physicians in the early management.
- Published
- 2020
37. Spontaneous thyroid nodule hemorrhage in the emergency department
- Author
-
Covino, Marcello, Princi, Pietro, De Luca, Giulio, Del Ciello, Annemilia, Simeoni, Benedetta, Bianchi, Antonio, De Crea, Carmela, Ojetti, Veronica, Raffaelli, Marco, Franceschi, Francesco, Covino M. (ORCID:0000-0002-6709-2531), Princi P., de Luca G., Del Ciello A., Simeoni B., Bianchi A., de Crea C. (ORCID:0000-0002-7303-9657), Ojetti V. (ORCID:0000-0002-8953-0707), Raffaelli M. (ORCID:0000-0002-1259-2491), Franceschi F. (ORCID:0000-0001-6266-445X), Covino, Marcello, Princi, Pietro, De Luca, Giulio, Del Ciello, Annemilia, Simeoni, Benedetta, Bianchi, Antonio, De Crea, Carmela, Ojetti, Veronica, Raffaelli, Marco, Franceschi, Francesco, Covino M. (ORCID:0000-0002-6709-2531), Princi P., de Luca G., Del Ciello A., Simeoni B., Bianchi A., de Crea C. (ORCID:0000-0002-7303-9657), Ojetti V. (ORCID:0000-0002-8953-0707), Raffaelli M. (ORCID:0000-0002-1259-2491), and Franceschi F. (ORCID:0000-0001-6266-445X)
- Abstract
Objective: Spontaneous thyroid gland hemorrhage is a rare event. The present retrospective study considered its clinical impact and management in a referral center. Methods: Clinical records of adult patients accessed in the last 10 years (2009-2018) in the Emergency Department of Policlinico Gemelli IRCCS were reviewed to study patients with spontaneous thyroid nodule hemorrhage. All demographic and radiologic or surgical parameters were included, with special attention to the characteristics of thyroid disease and clinical management. Results: Among the 631,129 adults who were registered during the period considered, 59 consecutive patients were included in the study. The mean age was 48.3 ± 14.3 years, with a prevalence of females. The main symptoms were acute neck pain, dyspnea, and dysphagia. All patients underwent ultrasound evaluation; computed tomography scan was performed on only 3 patients, finding one case of active intranodular bleeding requiring urgent surgery. Six patients required hospitalization; the others were discharged and referred for ambulatory endocrinology follow-up. Among them, 7 patients underwent surgery in the next 6 months, with malignant disease found in 3 cases (5.1%). Conclusion: Intrathyroidal spontaneous hemorrhage is a rare event, occurring in multinodular as well as in single-nodule thyroid disease. Although the clinical course is mostly benign, this condition should be carefully evaluated as, in rare circumstances, active bleeding could induce airway obstruction with the need for emergency surgery. Patients should be referred to endocrinology ambulatory follow-up because bleeding could arise as the first sign of malignant lesions in some cases.
- Published
- 2020
38. Unexpected macrophage activation syndrome in a healthy young woman: a case report
- Author
-
Saviano, Angela, Petrucci, M, Tilli, Pietro, Pignataro, G, Petruzziello, C, Giuliano, G, Ojetti, Veronica, Covino, Marcello, Franceschi, Francesco, Candelli, Marcello, Saviano, A (ORCID:0000-0002-2820-7180), Tilli, P, Ojetti, V (ORCID:0000-0002-8953-0707), Covino, M (ORCID:0000-0002-6709-2531), Franceschi, F (ORCID:0000-0001-6266-445X), Candelli, M (ORCID:0000-0001-8443-7880), Saviano, Angela, Petrucci, M, Tilli, Pietro, Pignataro, G, Petruzziello, C, Giuliano, G, Ojetti, Veronica, Covino, Marcello, Franceschi, Francesco, Candelli, Marcello, Saviano, A (ORCID:0000-0002-2820-7180), Tilli, P, Ojetti, V (ORCID:0000-0002-8953-0707), Covino, M (ORCID:0000-0002-6709-2531), Franceschi, F (ORCID:0000-0001-6266-445X), and Candelli, M (ORCID:0000-0001-8443-7880)
- Abstract
Macrophage activation syndrome (MAS) is a life-threatening condition and a medical emergency with a high-risk of mortality. It belongs to a group of diseases known as "hemophagocytic lymphohistiocytosis", characterized by a cytokine storm, with secretion of tumor necrosis factor, interleukins and interferon-gamma, and an inappropriate activation of macrophages and T-lymphocytes. Some inflammatory and systemic autoimmune diseases, such as systemic juvenile idiopathic arthritis, Still's disease and systemic lupus erythematosus, can develop into macrophage activation syndrome. This is the first episode of macrophage activation syndrome (MAS) in a young healthy woman. She arrived at the Emergency Department complaining of four days of weakness and fever not responsive to paracetamol. She had no significant past medical history, her mother suffered from rheumatoid arthritis. In the Emergency Department, we performed laboratory exams, autoimmune and infectious disease screening, bone marrow biopsy. The final diagnosis was of macrophage activation syndrome. Macrophage activation syndrome, in extremely rare cases, can arise independently years before the manifestation of an autoimmune disease. Persistent fever, high level of inflammatory markers and pancytopenia should raise suspicion in healthy people, especially when associated with a family history of autoimmune disease. Early diagnosis and consequent early treatment are fundamental to avoid progressive tissue damage that can lead to organ failure and death.
- Published
- 2020
39. A COMBINATION OF PRE- AND PROBIOTICS, VITAMINS, MINERALS, ANTIOXIDANTS AND ANTI-INFLAMMATORY AGENTS AS A NEW THERAPEUTIC APPROACH FOR INCREASED INTESTINAL PERMEABILITY: Abstract no.: P15.07
- Author
-
Ianiro, G., Ojetti, V., Gaetani, E., Laterza, L., Scaldaferri, F., Bartoli, Beghella F., De Martino, S., Dinoi, G., Gigante, G., Cammarota, G., Gasbarrini, G., and Gasbarrini, A.
- Published
- 2013
40. HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS: Abstract no.: P11.38
- Author
-
Gigante, G., Bove, V., Ojetti, V., Cammarota, G., Gasbarrini, G., and Gasbarrini, A.
- Published
- 2013
41. EFFICACY OF AMYTRIPTILINE IN IMPROVING INTESTINAL PERMEABILITY AND QUALITY OF LIFE IN PATIENTS WITH GASTROINTESTINAL DISORDERS: Abstract no.: P11.43
- Author
-
Gigante, G., Caracciolo, G., Bove, V., Ojetti, V., Ianiro, G., Cammarota, G., Gasbarrini, G., and Gasbarrini, A.
- Published
- 2013
42. A LOWER QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL BOWEL DISORDERS COMPARED TO THOSE WITH GASTRIC DYSPEPSIA: Abstract no.: P11.37
- Author
-
Gigante, G., Caracciolo, G., Cesario, V., Camapnale, M., Bove, V., Ojetti, V., Gasbarrini, G., and Gasbarrini, A.
- Published
- 2013
43. NICKEL FREE-DIET ENHANCES HELICOBACTER PYLORI ERADICATION RATE: Abstract no.: WS5.4
- Author
-
Campanale, M., Nucera, E., Bertucci, F., Tortora, A., Cesario, V., Gigante, G., Barbaro, F., di Rienzo, T. A., de Pasquale, T., Gasbarrini, G., Ojetti, V., Schiavino, D., and Gasbarrini, A.
- Published
- 2011
44. T04.02.17 INCREASING TREND IN EMERGENCY DEPARTMENT ADMISSIONS RATE FOR ACUTE DIVERTICULITIS FROM 2002 TO 2017: REAL-LIFE DATA OF FONDAZIONE POLICLINICO UNIVERSITARIO A. GEMELLI, IRCCS, ROME
- Author
-
Petruzziello, C., primary, Saviano, A., additional, Nista, E., additional, Giuri, G., additional, Franceschi, F., additional, and Ojetti, V., additional
- Published
- 2020
- Full Text
- View/download PDF
45. T04.02.4 THE EFFICACY OF A MIX OF THREE PROBIOTIC STRAINS IN REDUCING ABDOMINAL PAIN AND INFLAMMATORY BIOMARKERS IN ACUTE UNCOMPLICATED DIVERTICULITIS
- Author
-
Petruzziello, C., primary, Marannino, M., additional, Migneco, A., additional, Brigida, M., additional, Saviano, A., additional, Piccioni, A., additional, Franceschi, F., additional, and Ojetti, V., additional
- Published
- 2020
- Full Text
- View/download PDF
46. T01.01.23 REAL TIME DETERMINATION OF H PYLORI INFECTION THROUGH UREA BREATH TEST IN PATIENTS WITH ACTIVE UPPER GASTROINTESTINAL BLEEDING IN AN EMERGENCY SETTING: PRELIMINARY RESULTS
- Author
-
Ojetti, V., primary, Petruzziello, C., additional, Capone, M., additional, Pignataro, G., additional, Brigida, M., additional, Saviano, A., additional, Covino, M., additional, Candelli, M., additional, Saviano, L., additional, Piccioni, A., additional, and Franceschi, F., additional
- Published
- 2020
- Full Text
- View/download PDF
47. EP704 Is SOFA score reliable in a gynecologic oncology setting or is something missing? A retrospective study on predictors and risk factors for bloodstream infections
- Author
-
Corrado, G, primary, Franza, L, additional, Costantini, B, additional, Spanu, T, additional, Covino, M, additional, Ojetti, V, additional, Quagliozzi, L, additional, Biscione, A, additional, Taccari, F, additional, Fagotti, A, additional, Tamburrini, E, additional, and Scambia, G, additional
- Published
- 2019
- Full Text
- View/download PDF
48. The role of immune serological parameters and allergological tests in psoriasis
- Author
-
Ojetti, V, Aguilar Sanchez, J A, De Simone, C, Migneco, A, Capizzi, R, Schiavino, D, Nucera, E, Patriarca, G, Gasbarrini, G, and Gasbarrini, A
- Published
- 2008
49. Trends and prediction of antimicrobial susceptibility in urinary bacteria isolated in European emergency departments: the EuroUTI 2010-2016 Study
- Author
-
Quaegebeur A, Brunard L, Javaudin F, Vibet M, Bemer P, Le Bastard Q, Batard E, Montassier E, Roman F, Llorens P, Salvi F, Galeazzi R, Ortega M, Marco F, de Zarate MMO, Ceron R, Trovato F, Carpinteri G, Moustafa F, Romaszko J, Pedersen M, Westh H, Dejaune P, Fihman V, Joost I, Blumel B, Ruiz F, Corral G, Bieler D, Bergmann H, Granzer H, Carron P, Prod'hom G, Greub G, Del Castillo J, Gonzalez F, Juvin M, Occelli C, Ruimy R, Claret P, Lavigne J, Hausfater P, Robert J, Ramacciati N, Mencacci A, Tartaglia D, Rossi L, Ojetti V, Petruzziello C, Fiori B, Bonenfant J, Piau-Couape C, Dejoies L, Garcia-Garcia A, Cores-Calvo O, Van den Brand C, Van Veen S, Laribi S, Lartigue M, and EuroUTI 2010-2016 Study Grp
- Abstract
Objectives To assess recent trends in susceptibility to antibiotics among urinary isolates isolated in European emergency departments (EDs) and to identify isolates with a high (90% or more) predicted probability of susceptibility to fluoroquinolones or third-generation cephalosporins (3GCs). Methods In this cross-sectional study, we included urine cultures obtained from adult patients between 2010 and 2016 in 24 European EDs. Temporal trends were assessed using time-series analysis and multivariate logistic models. Multivariate logistic models were also used to predict susceptibility to fluoroquinolones or 3GCs from patient age and sex, year, month and ED. Results We included 88242 isolates. Time-series analysis found a significant increase in susceptibility to fluoroquinolones and no significant trend for susceptibility to 3GCs. Adjusting for patient age and sex, ED and organism, multivariate models showed that susceptibility to 3GCs decreased from 2014 to 2016, while susceptibility to fluoroquinolones increased in 2015 and 2016. Among isolates from 2016, multivariate models predicted high probability of susceptibility to fluoroquinolones in 11% of isolates (positive predictive value 91%) and a high probability of susceptibility to 3GCs in 35% of isolates (positive predictive value 94%). Conclusions Susceptibility of ED urinary isolates to fluoroquinolones increased from 2014, while susceptibility to 3GCs decreased from 2015. Predictive models identified isolates with a high probability of susceptibility to fluoroquinolones or 3GCs. The ability of such models to guide the empirical treatment of pyelonephritis in the ED remains to be determined.
- Published
- 2019
50. EFFECTS OF SHORT-TERM MODERATE ALCOHOL CONSUMPTION ON OXIDATIVE STRESS AND NUTRITIONAL STATUS IN HEALTHY MALES: 353
- Author
-
Leggio, L., Ferrulli, A., Ojetti, V., Abenavoli, L., DʼAngelo, C., Vonghia, L., Mirijello, A., Cardone, S., Leso, V., Malandrino, N., Capristo, E., Gasbarrini, G., Gasbarrini, A., and Addolorato, G.
- Published
- 2007
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.